Publikationen unserer Klinik sortiert nach Publikationsjahr

isTab: true
Zurück
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
Vor

Pankreasanastomosen bei operativer Versorgung der chronischen Pankreatitis
Bellon E, Izbicki J, Bockhorn M
CHIRURG. 2017;88(1):18-24.

IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo
Brockmann L, Gagliani N, Steglich B, Giannou A, Kempski J, Pelczar P, Geffken M, Mfarrej B, Huber F, Herkel J, Wan Y, Esplugues E, Battaglia M, Krebs C, Flavell R, Huber S
J IMMUNOL. 2017;198(3):1130-1141.

HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer
Ghadban T, Dibbern J, Reeh M, Miro J, Tsui T, Wellner U, Izbicki J, Güngör C, Vashist Y
APOPTOSIS. 2017;22(3):369-380.

MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays
Hinsch A, Buchholz M, Odinga S, Borkowski C, Koop C, Izbicki J, Wurlitzer M, Krech T, Wilczak W, Steurer S, Jacobsen F, Burandt E, Stahl P, Simon R, Sauter G, Schlüter H
J MASS SPECTROM. 2017 [Epub ahead of print].

Anesthetic considerations for patients with esophageal achalasia undergoing peroral endoscopic myotomy
Löser B, Werner Y, Punke M, Saugel B, Haas S, Reuter D, Mann O, Duprée A, Schachschal G, Rösch T, Petzoldt M
CAN J ANESTH. 2017 [Epub ahead of print].

Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs)
Nentwich M, Menzel K, Reeh M, Uzunoglu F, Ghadban T, Bachmann K, Schrader J, Bockhorn M, Izbicki J, Perez D
EJSO-EUR J SURG ONC. 2017 [Epub ahead of print].

Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas
Precht C, Blessmann M, Kluwe L, Scheld T, Schön G, Henningsen A, Pflug C, Smeets R, Heiland M, Gröbe A
EUR J ORAL SCI. 2017 [Epub ahead of print].

Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer
Reeh M, Ghadban T, Dedow J, Vettorazzi E, Uzunoglu F, Nentwich M, Kluge S, Izbicki J, Vashist Y
WORLD J SURG. 2017;41(1):208-215.

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
Wilczak W, Rashed S, Hube-Magg C, Kluth M, Simon R, Büscheck F, Clauditz T, Grupp K, Minner S, Tsourlakis M, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Sauter G, Izbicki J, Huland H, Schlomm T, Steurer S, Krech T, Lebok P
CARCINOGENESIS. 2017;38(1):19-27.

Lectin Histochemistry for Metastasizing and Non-metastasizing Cancer Cells
Wolters-Eisfeld G, Schumacher U
Methods Mol Biol. 2017;1560:121-132.

Duodenal Electric Stimulation: Results of a First-in-Man Study
Aberle J, Busch C, Veigel J, Duprée A, Roesch T, Zu Eulenburg C, Paschen B, Scholz B, Wolter S, Sauer N, Ludwig K, Izbicki J, Mann O
OBES SURG. 2016;26(2):369-75.

Influence of hypoxia-dependent factors on the progression of neuroblastoma
Ameis H, Drenckhan A, Freytag M, Izbicki J, Supuran C, Reinshagen K, Holland-Cunz S, Gros S
PEDIATR SURG INT. 2016;32(2):187-92.

Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma
Ameis H, Drenckhan A, Freytag M, Izbicki J, Supuran C, Reinshagen K, Holland-Cunz S, Gros S
J ENZYM INHIB MED CH. 2016;31(3):404-9.

Wie bewerkstelligt robotische Chirurgie die Fallstricke der Rektumchirurgie? Eine europäische multizentrische Evaluation
Baukloh J, Reeh M, Spinoglio G, Coratti A, Mirasolo V, Bartolini I, Priora F, Hiller J, Kollbeck S, Izbicki J, Gomez Fleitas M, Gomez Ruiz M, Perez D
Z GASTROENTEROL. 2016.

The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk
Becker J, May A, Gerges C, Anders M, Schmidt C, Veits L, Noder T, Mayershofer R, Kreuser N, Manner H, Venerito M, Hofer J, Lyros O, Ahlbrand C, Arras M, Hofer S, Heinrichs S, Weise K, Hess T, Böhmer A, Kosiol N, Kiesslich R, Izbicki J, Hölscher A, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Ott K, Schmidt T, Nöthen M, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Knapp M, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J
CANCER MED-US. 2016;5(5):888-91.

Definition and classification of chyle leak after pancreatic operation
Besselink M, van Rijssen L, Bassi C, Dervenis C, Montorsi M, Adham M, Asbun H, Bockhorn M, Strobel O, Büchler M, Busch O, Charnley R, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Izbicki J, Lillemoe K, Neoptolemos J, Sarr M, Shrikhande S, Sitarz R, Vollmer C, Yeo C, Hartwig W, Wolfgang C, Gouma D
SURGERY. 2016;161(2):365-372.

HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer
Bogoevska V, Wolters-Eisfeld G, Hofmann B, El Gammal A, Mercanoglu B, Gebauer F, Vashist Y, Bogoevski D, Perez D, Gagliani N, Izbicki J, Bockhorn M, Güngör C
Oncogene. 2016 [Epub ahead of print].

Endoscopic ultrasound-guided drainage of abdominal fluid collections after pancreatic surgery
Denzer U, Sioulas A, Abdulkarim M, Groth S, Rösch T, Busch C, Izbicki J, Ittrich H, Adam G, Schachschal G
Z GASTROENTEROL. 2016;54(9):1047-53.

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
Gebauer F, Gelis S, Zander H, Meyer K, Wolters-Eisfeld G, Izbicki J, Bockhorn M, Tachezy M
ONCOTARGET. 2016;7(15):20945-52.

Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis
Gebauer F, Wicklein D, Tachezy M, Grob T, Steinemann D, Manukjan G, Göhring G, Schlegelberger B, Maar H, Izbicki J, Bockhorn M, Schumacher U
ANTICANCER RES. 2016;36(4):1507-18.

Women's Perception of Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES): Results of a Survey of Female Medical Staff and Literature Review
Gerntke C, Kersten J, Schön G, Mann O, Stark M, Benhidjeb T
SURG INNOV. 2016;23(2):201-211.

Shuntchirurgie für die Dialyse
Ghadban T, Weissmann V, Ittrich H, Janneck M, König A
Allgemein- und Viszeralchirurgie up2date. 2016;10(3):203-218.

Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the esophageus
Ghadban T, Miro J, Trump F, Tsui T, Uzunoglu F, Reeh M, Gebauer F, Bachmann K, Wellner U, Kalinin V, Pantel K, Izbicki J, Vashist Y
CLIN GENET. 2016;90(4):343-50.

In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
Ghadban T, Jessen A, Reeh M, Dibbern J, Mahner S, Mueller V, Wellner U, Güngör C, Izbicki J, Vashist Y
INT J MOL MED. 2016;38(4):1296-302.

Prognostic Significant or Not? The Positive Circumferential Resection Margin in Esophageal Cancer: Impact on Local Recurrence and Overall Survival in Patients Without Neoadjuvant Treatment
Ghadban T, Reeh M, Koenig A, Nentwich M, Bellon E, Izbicki J, Vashist Y, Kutup A
ANN SURG. 2016 [Epub ahead of print].

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
Gharahkhani P, Fitzgerald R, Vaughan T, Palles C, Gockel I, Tomlinson I, Buas M, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer A, Izbicki J, Hölscher A, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen M, Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love S, MacDonald D, Moayyedi P, Prenen H, Watson R, Iyer P, Anderson L, Bernstein L, Chow W, Hardie L, Lagergren J, Liu G, Risch H, Wu A, Ye W, Bird N, Shaheen N, Gammon M, Corley D, Caldas C, Moebus S, Knapp M, Peters W, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman D, Jankowski J, Schumacher J
LANCET ONCOL. 2016;17(10):1363-1373.

Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission
Hamprecht A, Rohde A, Behnke M, Feihl S, Gastmeier P, Gebhardt F, Kern W, Knobloch J, Mischnik A, Obermann B, Querbach C, Peter S, Schneider C, Schröder W, Schwab F, Tacconelli E, Wiese-Posselt M, Wille T, Willmann M, Seifert H, Zweigner J
J ANTIMICROB CHEMOTH. 2016;71(10):2957-63.

Attachment, Viability and Adipodifferentiation of Pre-adipose Cells on Silk Scaffolds with and Without Co-expressed FGF-2 and VEGF.
Hanken H, Göhler F, Smeets R, Heiland M, Gröbe A, Friedrich R, Busch C, Blessmann M, Kluwe L, Hartjen P
IN VIVO. 2016;30(5):567-72.

Characterization of different CTC subpopulations in non-small cell lung cancer
Hanssen A, Wagner J, Gorges T, Tänzer A, Uzunoglu F, Driemel C, Stoecklein N, Knoefel W, Angenendt S, Hauch S, Atanackovic D, Loges S, Riethdorf S, Pantel K, Wikman H
SCI REP-UK. 2016;6:28010.

Pancreatic surgery
Izbicki J, Montorsi M
Updates Surg. 2016;68(3):215.

The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus
Kilic E, Tennstedt P, Högner A, Lebok P, Sauter G, Bokemeyer C, Izbicki J, Wilczak W
VIRCHOWS ARCH. 2016;468(4):483-92.

Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney
Krebs C, Paust H, Krohn S, Koyro T, Brix S, Riedel J, Bartsch P, Wiech T, Meyer-Schwesinger C, Huang J, Fischer N, Busch C, Mittrücker H, Steinhoff U, Stockinger B, Perez L, Wenzel U, Janneck M, Steinmetz O, Gagliani N, Stahl R, Huber S, Turner J, Panzer U
IMMUNITY. 2016;45(5):1078-1092.

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Kuske A, Gorges T, Tennstedt P, Tiebel A, Pompe R, Preißer F, Prues S, Mazel M, Markou A, Lianidou E, Peine S, Alix-Panabières C, Riethdorf S, Beyer B, Schlomm T, Pantel K
SCI REP-UK. 2016;6:39736.

High Ki67 expression is an independent good prognostic marker in colorectal cancer
Melling N, Kowitz C, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki J, Marx A
J CLIN PATHOL. 2016;69(3):209-14.

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer
Melling N, Taskin B, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Heinzer H, Tsourlakis M, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, Sauter G, Steurer S, Schlomm T, Krech T
PROSTATE. 2016;76(3):259-72.

Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment
Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu F, Vashist Y, Izbicki J, Bogoevski D
SURGERY. 2016;159(6):1548-56.

Subtotal Esophagectomy: Abdominothoracic Approach
Nentwich M, Kutup A
2016. Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. Clavien P, Sarr M, Fong Y, Miyazaki M (Hrsg.). 2. Aufl. Springer Berlin, 89-98.

Abdominothoracic Esophagohemigastrectomy
Nentwich M, Bogoevski D
2016. Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. Clavien P, Sarr M, Fong Y, Miyazaki M (Hrsg.). 2. Aufl. Springer Berlin, 209-214.

Non-trauma Emergency Pancreatoduodenectomies: A Single-Center Retrospective Analysis
Nentwich M, Reeh M, Uzunoglu F, Bachmann K, Bockhorn M, Izbicki J, Vashist Y
WORLD J SURG. 2016;40(9):2261-6.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.
Nienstedt J, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Möbius C, Münscher A, Knecht R, Blessmann M, Heiland M, Pflug C
CLIN ORAL INVEST. 2016 [Epub ahead of print].

A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease
Pelczar P, Witkowski M, Perez L, Kempski J, Hammel A, Brockmann L, Kleinschmidt D, Wende S, Haueis C, Bedke T, Krasemann S, Steurer S, Booth C, Busch C, König A, Rauch U, Benten D, Izbicki J, Rösch T, Lohse A, Strowig T, Gagliani N, Flavell R, Huber S
SCIENCE. 2016;354(6310):358-362.

Combined modified en bloc corpectomy with replacement of the aorta in curative interdisciplinary treatment of a large osteosarcoma infiltrating the aorta
Pilger A, Tsilimparis N, Bockhorn M, Trepel M, Dreimann M
EUR SPINE J. 2016;25 (Suppl 1):58-62.

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence
Pust A, Kylies D, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Salomon G, Tsourlakis M, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, Sauter G, Steurer S, Krech T, Schlomm T, Melling N
HUM PATHOL. 2016;48:102-10.

The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer
Reeh M, Metze J, Uzunoglu F, Nentwich M, Ghadban T, Wellner U, Bockhorn M, Kluge S, Izbicki J, Vashist Y
MEDICINE. 2016;95(7):e2724.

Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer
Schirmer M, Lüske C, Roppel S, Schaudinn A, Zimmer C, Pflüger R, Haubrock M, Rapp J, Güngör C, Bockhorn M, Hackert T, Hank T, Strobel O, Werner J, Izbicki J, Johnsen S, Gaedcke J, Brockmöller J, Ghadimi B
J NATL CANCER I. 2016;108(5):djv387.

Microvascular stent anastomosis using N-fibroin stents: feasibility, ischemia time, and complications
Smeets R, Vorwig O, Wöltje M, Gaudin R, Lübke A, Beck-Broichsitter B, Rheinnecker M, Heiland M, Grupp K, Gröbe A, Hanken H
ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL. 2016;121(5):e97-e103.

Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis
Tachezy M, Gebauer F, Janot M, Uhl W, Zerbi A, Montorsi M, Perinel J, Adham M, Dervenis C, Agalianos C, Malleo G, Maggino L, Stein A, Izbicki J, Bockhorn M
SURGERY. 2016;160(1):136-44.

The Effects of Pancreatic Microcirculatory Disturbances on Histopathologic Tissue Damage and the Outcome in Severe Acute Pancreatitis
Tomkötter L, Erbes P, Trepte C, Hinsch A, Dupree A, Bockhorn M, Mann O, Izbicki J, Bachmann K
PANCREAS. 2016;45(2):248-253.

How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant
Tsui T, Heumann A, Vashist Y, Izbicki J
LANGENBECK ARCH SURG. 2016;401(4):565-71.

Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma
Wachowiak R, Mayer S, Kaifi J, Gebauer F, Izbicki J, Lacher M, Bockhorn M, Tachezy M
ANTICANCER RES. 2016;36(8):3991-5.

Early adverse events of per-oral endoscopic myotomy
Werner Y, von Renteln D, Noder T, Schachschal G, Denzer U, Groth S, Nast J, Kersten J, Petzoldt M, Adam G, Mann O, Repici A, Hassan C, Rösch T
GASTROINTEST ENDOSC. 2016 [Epub ahead of print].

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry
Bachmann K, Neumann A, Hinsch A, Nentwich M, El Gammal A, Vashist Y, Perez D, Bockhorn M, Izbicki J, Mann O
J SURG ONCOL. 2015;111(3):316-23.

Roboter-assistierte versus offene tiefe anteriore Rektumresektion – Initiale Erfahrung im Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Izbicki J, Perez D
Z GASTROENTEROL. 2015.

Roboter assistierte versus offene Chirurgie bei tiefem Rektumkarzinom - Initiale Erfahrung in Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Hiller J, Izbicki J, Perez D
2015.

Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma
Becker J, May A, Gerges C, Anders M, Veits L, Weise K, Czamara D, Lyros O, Manner H, Terheggen G, Venerito M, Noder T, Mayershofer R, Hofer J, Karch H, Ahlbrand C, Arras M, Hofer S, Mangold E, Heilmann-Heimbach S, Heinrichs S, Hess T, Kiesslich R, Izbicki J, Hölscher A, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Müller-Myhsok B, Ott K, Schmidt T, Whiteman D, Vaughan T, Nöthen M, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J
CANCER RES. 2015;4(11):1700-4.

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers
Burdelski C, Barreau Y, Simon R, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Sauter G, Wittmer C, Steurer S, Adam M, Huland H, Schlomm T, Tsourlakis M, Quaas A
HUM PATHOL. 2015;46(4):514-23.

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer
Burdelski C, Ruge O, Melling N, Koop C, Simon R, Steurer S, Sauter G, Kluth M, Hube-Magg C, Minner S, Wittmer C, Wilczak W, Hinsch A, Lebok P, Izbicki J, Heinzer H, Graefen M, Huland H, Schlomm T, Krech T
EXP MOL PATHOL. 2015;98(3):419-426.

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
Burdelski C, Strauss C, Tsourlakis M, Kluth M, Hube-Magg C, Melling N, Lebok P, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Krech T, Sauter G, Wilczak W, Simon R, Schlomm T, Steurer S
ONCOTARGET. 2015.

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
Burdelski C, Menan D, Tsourlakis M, Kluth M, Hube-Magg C, Melling N, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Simon R, Schlomm T, Steurer S, Krech T
BMC CANCER. 2015;15:538.

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
Burdelski C, Bujupi E, Tsourlakis M, Hube-Magg C, Kluth M, Melling N, Lebok P, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Wilczak W, Simon R, Schlomm T, Steurer S, Krech T
PLOS ONE. 2015;10(6):e0128525.

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer
Burdelski C, Reiswich V, Hube-Magg C, Kluth M, Minner S, Koop C, Graefen M, Heinzer H, Tsourlakis M, Wittmer C, Huland H, Simon R, Schlomm T, Sauter G, Steurer S
CLIN CANCER RES. 2015;21(15):3471-9.

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer
Childs E, Mocci E, Campa D, Bracci P, Gallinger S, Goggins M, Li D, Neale R, Olson S, Scelo G, Amundadottir L, Bamlet W, Bijlsma M, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita H, Canzian F, Capurso G, Cavestro G, Chaffee K, Chanock S, Cleary S, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman J, Holcatova I, Holly E, Hoover R, Hung R, Janout V, Key T, Kupcinskas J, Kurtz R, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos J, Oberg A, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon R, Strobel O, Tavano F, Vashist Y, Vodicka P, Wolpin B, Yu H, Petersen G, Risch H, Klein A
NAT GENET. 2015;47(8):911-6.

Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic Syndrome: a case-control study
Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T
BMJ OPEN. 2015;5(3):e005659.

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
Gebauer F, Tachezy M, Vashist Y, Marx A, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(2):493-9.

Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, El Gammal A, Miro J, Wellner U, Pantel K, Izbicki J, Vashist Y
CANCER GENET-NY. 2015;208(12):595–601.

Correction to: An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2015;60(2):107.

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion
Grupp K, Roettger L, Kluth M, Hube-Magg C, Simon R, Lebok P, Minner S, Tsourlakis M, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Sauter G, Wilczak W, Huland H, Schlomm T, Steurer S, Krech T
Oncology reports. 2015;34(3):1211-20.

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence
Gu L, Frommel S, Oakes C, Simon R, Grupp K, Gerig C, Bär D, Robinson M, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, Yaspo M, Brors B, Korbel J, Schlomm T, Sauter G, Eils R, Plass C, Santoro R
NAT GENET. 2015;47(1):22-30.

High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer
Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano L, Izbicki J, Marx A
AM J CLIN PATHOL. 2015;8(7):8227-35.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann B, Schlüter L, Lange P, Mercanoglu B, Ewald F, Fölster A, Picksak A, Harder S, El Gammal A, Grupp K, Güngör C, Drenckhan A, Schlüter H, Wagener C, Izbicki J, Jücker M, Bockhorn M, Wolters-Eisfeld G
MOL CANCER. 2015;14(1):109.

Fighting for Academic Surgical Oncology
Izbicki J
ANN SURG. 2015;262(5):701-3.

ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts
Kebenko M, Drenckhan A, Gros S, Jücker M, Grabinski N, Ewald F, Grottke A, Schultze A, Izbicki J, Bokemeyer C, Wellbrock J, Fiedler W
CELL SIGNAL. 2015;27(2):373-81.

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial
Keck T, Wellner U, Bahra M, Klein F, Sick O, Niedergethmann M, Wilhelm T, Farkas S, Börner T, Bruns C, Kleespies A, Kleeff J, Mihaljevic A, Uhl W, Chromik A, Fendrich V, Heeger K, Padberg W, Hecker A, Neumann U, Junge K, Kalff J, Glowka T, Werner J, Knebel P, Piso P, Mayr M, Izbicki J, Vashist Y, Bronsert P, Bruckner T, Limprecht R, Diener M, Rossion I, Wegener I, Hopt U
ANN SURG. 2015;263(3):440-9.

Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion
Lin Y, Bhuwania R, Gromova K, Failla A, Lange T, Riecken K, Linder S, Kneussel M, Izbicki J, Windhorst S
ONCOTARGET. 2015;6(21):18577-89.

Ex vivo aorta patch model for analysis of cellular adhesion
Lin Y, Thata R, Failla A, Geissen M, Daum G, Windhorst S
TISSUE CELL. 2015;47(3):266-72.

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
Melling N, Thomsen E, Tsourlakis M, Kluth M, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Wilczak W, Huland H, Simon R, Schlomm T, Steurer S, Krech T
CARCINOGENESIS. 2015;36(11):1333-40.

Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization
Melling N, Simon R, Izbicki J, Terracciano L, Bokemeyer C, Sauter G, Marx A
AM J CLIN PATHOL. 2015;8(6):7009-15.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
Melling N, Harutyunyan L, Hube-Magg C, Kluth M, Simon R, Lebok P, Minner S, Tsourlakis M, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Steurer S, Izbicki J, Sauter G, Wilczak W, Schlomm T, Krech T
PLOS ONE. 2015;10(7):e0134614.

Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Melling N, Muth J, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki J, Marx A
DIAGN PATHOL. 2015;10:125.

Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer
Melling N, Simon R, Mirlacher M, Izbicki J, Stahl P, Terracciano L, Bokemeyer C, Sauter G, Marx A
HISTOPATHOLOGY. 2015;68(2):191-8.

Salvage Completion Pancreatectomies as Damage Control for Post-pancreatic Surgery Complications: A Single-Center Retrospective Analysis
Nentwich M, El Gammal A, Lemcke T, Ghadban T, Bellon E, Melling N, Bachmann K, Reeh M, Uzunoglu F, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(6):1550-6.

Discontinuing MEK inhibitors in tumor cells with an acquired resistance increases migration and invasion
Nörz D, Grottke A, Bach J, Herzberger C, Hofmann B, Nashan B, Jücker M, Ewald F
CELL SIGNAL. 2015;27(11):2191-200.

Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M, Nentwich M, Asani S, Uzunoglu F, Bockhorn M, Sauter G, Rösch T, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2015;19(4):587-93.

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Reeh M, Harms-Effenberger K, Koenig A, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu F, Vashist Y, Izbicki J, Pantel K, Bockhorn M
ANN SURG. 2015;261(6):1124-30.

Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1
Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre J, Banchereau J, Levy Y, Seddiki N
AIDS. 2015;29(5):519-30.

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki J, Bokemeyer C, Simon R, Sauter G, Marx A
BMC GASTROENTEROL. 2015;15(1):7.

Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays
Stahl P, Schnellert J, Koop C, Simon R, Marx A, Izbicki J, Sauter G, Quaas A
PATHOL ONCOL RES. 2015;21(4):1183-9.

Identification of HERC5 and its potential role in NSCLC progression
Wrage M, Hagmann W, Kemming D, Uzunoglu F, Riethdorf S, Harms-Effenberger K, Westphal M, Lamszus K, Kim S, Becker N, Izbicki J, Sandoval J, Esteller M, Pantel K, Risch A, Wikman-Kocher H
INT J CANCER. 2015;136(10):2264-72.

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
Zabalza C, Adam M, Burdelski C, Wilczak W, Wittmer C, Kraft S, Krech T, Steurer S, Koop C, Hube-Magg C, Graefen M, Heinzer H, Minner S, Simon R, Sauter G, Schlomm T, Tsourlakis M
ONCOTARGET. 2015;6(14):12822-12834.

Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection
Anders M, Bähr C, El-Masry M, Marx A, Koch M, Seewald S, Schachschal G, Adler A, Soehendra N, Izbicki J, Neuhaus P, Pohl H, Rösch T
GUT. 2014;63(10):1535-1543.

Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagus
Anders M, Lucks Y, El-Masry M, Quaas A, Rösch T, Schachschal G, Bähr C, Gauger U, Sauter G, Izbicki J, Marx A
CLIN GASTROENTEROL H. 2014;12(3):405-10.

When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery
Asbun H, Conlon K, Fernandez-Cruz L, Riess H, Shrikhande S, Adham M, Bassi C, Bockhorn M, Büchler M, Charnley R, Dervenis C, Fingerhutt A, Gouma D, Hartwig W, Imrie C, Izbicki J, Lillemoe K, Milicevic M, Montorsi M, Neoptolemos J, Sandberg A, Sarr M, Vollmer C, Yeo C, Traverso L
SURGERY. 2014;155(5):887-892.

Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma
Atac A, Riecke B, Assaf A, Gröbe A, Friedrich R, Heiland M, Izbicki J, Kluwe L, Blessmann M
ANTICANCER RES. 2014;34(1):235-8.

Beger and Frey Procedures for Treatment of Chronic Pancreatitis: Comparison of Outcomes at 16-Year Follow-Up
Bachmann K, Tomkoetter L, Erbes P, Hofmann B, Reeh M, Perez D, Vashist Y, Bockhorn M, Izbicki J, Mann O
J AM COLL SURGEONS. 2014;219(2):208-216.

Neuroendokrine Tumoren des Verdauungstrakts - Daten des deutschen NET-Registers
Begum N, Maasberg S, Plöckinger U, Anlauf M, Rinke A, Pöpperl G, Lehnert H, Izbicki J, Krausch M, Vashist Y, Raffel A, Bürk C, Hoffmann J, Goretzki P, Pape U
ZBL CHIR. 2014;139(3):276-83.

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Bockhorn M, Uzunoglu F, Adham M, Imrie C, Milicevic M, Sandberg A, Asbun H, Bassi C, Büchler M, Charnley R, Conlon K, Cruz L, Dervenis C, Fingerhutt A, Friess H, Gouma D, Hartwig W, Lillemoe K, Montorsi M, Neoptolemos J, Shrikhande S, Takaori K, Traverso W, Vashist Y, Vollmer C, Yeo C, Izbicki J
SURGERY. 2014;155(6):977-988.

Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface
Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J, Hopt U, Keck T, Stickeler E, Passlick B, Schilling O, Reiss C, Vashist Y, Brabletz T, Lotz J, Olesch J, Werner M, Wellner U
J PATHOL. 2014;234(3):410-22.

Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
Bronsert P, Kohler I, Timme S, Kiefer S, Werner M, Schilling O, Vashist Y, Makowiec F, Brabletz T, Hopt U, Bausch D, Kulemann B, Keck T, Wellner U
SURGERY. 2014;156(1):97-108.

Psychosomatische Aspekte des chronischen Unterbauchschmerzsyndroms: Psychometrische Ergebnisse der Pilotphase einer interdisziplinären Sprechstunde
Brünahl C, Riegel B, Höink J, Kutup A, Eichelberg E, Löwe B
SCHMERZ. 2014;28(3):311-318.

Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice
Burandt E, Schreiber M, Stein A, Minner S, Clauditz T, Bokemeyer C, Jänicke F, Fisch M, Izbicki J, Knecht R, Sauter G, Stahl P
GENE CHROMOSOME CANC. 2014;53(3):228-39.

Test-retest reliability of an infectious disease questionnaire and evaluation of self-assessed vulnerability to infections: findings of Pretest 2 of the German National Cohort
Castell S, Akmatov M, Obi N, Flesh-Janys D, Nieters A, Kemmling Y, Pessler F, Krause G
BUNDESGESUNDHEITSBLATT. 2014;57(11):1300-7.

Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)
Clauditz T, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, Münscher A
PATHOL RES PRACT. 2014;210(10):649-655.

Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib
Drenckhan A, Grob T, Dupree A, Dohrmann T, Mann O, Izbicki J, Gros S
LANGENBECK ARCH SURG. 2014;399(7):879-88.

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression
Eberhard J, Hartjen P, Kummer S, Schmidt R, Bockhorn M, Lehmann C, Balagopal A, Hauber J, Lunzen J, Schulze zur Wiesch J
PLOS ONE. 2014;9(11):e111323.

The role of RANK-signaling in tumor cell proliferation and migration in pancreatic adenocarcinoma.
El Gammal A, Sander N, Aljonna F, Friedenberger H, Leonie K, Güngör C, Wolters-Eisfeld G, Hofmann B, Bockhorn M, Izbicki J, Perez D
2014;suppl; abstr e15193.

Obesity research: Status quo and future outlooks
El Gammal A, Dupree A, Wolter S, Aberle J, Izbicki J, Güngör C, Mann O
World J of Transl Med. 2014;3(3):119-132.

Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors
Ewald F, Nörz D, Grottke A, Hofmann B, Nashan B, Jücker M
INVEST NEW DRUG. 2014;32(6):1144-54.

Predictive Factors for Postoperative Pancreatic Fistula - Reply
Gebauer F, Izbicki J, Bockhorn M
ANN SURG. 2014;261(4):E99-E100.

Glomangioma of the lung: a case report and review of the literature
Gebauer F, Quaas A, Izbicki J, Vashist Y
J Med Case Rep. 2014;8(1):5.

Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer
Gebauer F, Wicklein D, Horst J, Sundermann P, Maar H, Streichert T, Tachezy M, Izbicki J, Bockhorn M, Schumacher U
PLOS ONE. 2014;9(11):e113023.

Serum EpCAM expression in pancreatic cancer
Gebauer F, Struck L, Tachezy M, Vashist Y, Wicklein D, Schumacher U, Izbicki J, Bockhorn M
ANTICANCER RES. 2014;34(9):4741-4746.

Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors
Ghadban T, Perez D, Vashist Y, Bockhorn M, Koenig A, El Gammal A, Izbicki J, Metzger U, Hauswirth F, Frosina D, Jungbluth A
EJSO-EUR J SURG ONC. 2014;40(10):1307-1312.

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2014;59(12):661-666.

Chronische Pankreatitis
Ghadban T, Bachmann K, König A, Ittrich H, Groth S, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(3): 219-232.

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma
Gröbe A, Eichhorn W, Fraederich M, Kluwe L, Vashist Y, Wikner J, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M
J ORAL PATHOL MED. 2014;43(3):205-10.

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer
Grupp K, Ospina-Klinck D, Tsourlakis M, Koop C, Wilczak W, Adam M, Simon R, Sauter G, Izbicki J, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A
PROSTATE. 2014;74(10):1012-22.

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
Grupp K, Boumesli R, Tsourlakis M, Koop C, Wilczak W, Adam M, Sauter G, Simon R, Izbicki J, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A
INT J CANCER. 2014;135(6):1399-1407.

High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions
Grupp K, Wilking J, Prien K, Hube-Magg C, Sirma H, Simon R, Steurer S, Budäus L, Haese A, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
EUR J CANCER. 2014;50(4):852-61.

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Grupp K, Habermann M, Sirma H, Simon R, Steurer S, Hube-Magg C, Prien K, Burkhardt L, Jedrzejewska K, Salomon G, Heinzer H, Wilczak W, Kluth M, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
MODERN PATHOL. 2014;27(1):96-106.

Pancreatic cancer
Güngör C, Hofmann B, Wolters-Eisfeld G, Bockhorn M
BRIT J PHARMACOL. 2014;171(4):849-858.

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
Hanken H, Gaudin R, Gröbe A, Fraederich M, Eichhorn W, Smeets R, Simon R, Sauter G, Grupp K, Izbicki J, Sehner S, Heiland M, Blessmann M
J ORAL PATHOL MED. 2014;43(4):304-8.

Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)
Hartwig W, Vollmer C, Fingerhut A, Yeo C, Neoptolemos J, Adham M, Andrén-Sandberg A, Asbun H, Bassi C, Bockhorn M, Charnley R, Conlon K, Dervenis C, Fernandez-Cruz L, Friess H, Gouma D, Imrie C, Lillemoe K, Milićević M, Montorsi M, Shrikhande S, Vashist Y, Izbicki J, Büchler M
SURGERY. 2014;156(1):1-14.

ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer
Hofmann B, Stehr A, Dohrmann T, Güngör C, Herich L, Hiller J, Harder S, Ewald F, Gebauer F, Tachezy M, Precht C, Izbicki J, Bockhorn M, Wagener C, Wolters-Eisfeld G
CLIN CANCER RES. 2014;20(23):6117-26.

Multimodale Therapie des Ösophaguskarzinoms: Pro und Kontra
Hölscher A, Fetzner U, Uzunoglu F, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(3):199-214.

Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis
Hölscher A, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki J
EUR J CANCER. 2014;50(17):2950-7.

Imaging of appendicitis in adults
Karul M, Berliner C, Keller S, Tsui T, Yamamura J
ROFO-FORTSCHR RONTG. 2014;186(6):551-558.

What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy
Kutup A, Nentwich M, Bollschweiler E, Bogoevski D, Izbicki J, Hölscher A
ANN SURG. 2014;260(6):1016-1022.

Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer
Lange T, Kupfernagel M, Wicklein D, Gebauer F, Maar H, Brügge K, Müller I, Simon R, Schlomm T, Sauter G, Schumacher U
CLIN CANCER RES. 2014;20(7):1791-802.

Highly efficient delivery of siRNA to a heart transplant model by a novel cell penetrating peptide-dsRNA binding domain
Li H, Zheng X, Koren V, Vashist Y, Tsui T
INT J PHARMACEUT. 2014;469(1):206-13.

Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells
Lin Y, Izbicki J, König A, Habermann J, Blechner C, Lange T, Schumacher U, Windhorst S
INT J CANCER. 2014;134(7):1571-82.

Cathepsin E generates a sumoylated intracellular fragment of the cell adhesion molecule L1 to promote neuronal and Schwann cell migration as well as myelination
Lutz D, Wolters-Eisfeld G, Schachner M, Kleene R
J NEUROCHEM. 2014;128(5):713-24.

Zertifizierungen in der onkologischen Chirurgie: Bedeutung für die Wahl der Behandlungsstätte
Melling N, Drabik A, El Gammal A, Antonakis F, Darmann I, Izbicki J, Bockhorn M
CHIRURG. 2014;86(7):687-695.

Limits of surgery for pancreatic cancer
Nentwich M, König A, Izbicki J
Rozhl Chir. 2014;93(9):445-449.

Pankreaskarzinome und periampulläre Karzinome
Nentwich M, König A, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(5):319-337.

Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus
Nentwich M, Loga K, Reeh M, Uzunoglu F, Marx A, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2014;18(2):242-9.

Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines
Nitsch E, Mina S, Brammer I, Pace A, Schuch G, Bokemeyer C, Zander A, Kröger N, Ayuketang F
ANTICANCER RES. 2014;34(4):1779-84.

Molecular changes in pre-metastatic lymph nodes of esophageal cancer patients
Otto B, Koenig A, Tolstonog G, Jeschke A, Klätschke K, Vashist Y, Wicklein D, Wagener C, Izbicki J, Streichert T
PLOS ONE. 2014;9(7):e102552.

The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer
Rawnaq T, Dietrich L, Wolters-Eisfeld G, Uzunoglu F, Vashist Y, Bachmann K, Simon R, Izbicki J, Bockhorn M, Güngör C
MOL CANCER RES. 2014;12(5):670-80.

Rescue bedside laparotomy in the intensive care unit in patients too unstable for transport to the operating room
Schreiber J, Nierhaus A, Vettorazzi E, Braune S, Frings D, Vashist Y, Izbicki J, Kluge S
CRIT CARE. 2014;18(3):R123.

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)
Tachezy M, Gebauer F, Petersen C, Arnold D, Trepel M, Wegscheider K, Schafhausen P, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2014;14(1):411.

Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer
Tachezy M, Tiebel A, Gebauer F, Kutup A, Tharun L, Pantel K, Izbicki J, Vashist Y
HISTOPATHOLOGY. 2014;29(11):1467-1475.

Activated Leukocyte Cell Adhesion Molecule (CD166): An "Inert" Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki J, Bockhorn M
STEM CELLS. 2014;32(6):1429-1436.

Appendicitis: Risk Factors, Management Strategies and Clinical Implications.
Tahir E, Avanesov M, Heumann A, Yamamura J, Karul M
2014.

Successful management of esophageal necrosis after endovascular repair of chronic type B aortic dissection
Tobisch A, Ittrich H, Izbicki J, Koenig A
ANN THORAC SURG. 2014;98(6):2209-2211.

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma
Tol J, Gouma D, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun H, Bockhorn M, Büchler M, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki J, Lillemoe K, Milicevic M, Neoptolemos J, Shrikhande S, Vollmer C, Yeo C, Charnley R
SURGERY. 2014;156(3):591-600.

βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Tsourlakis M, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, Graefen M, Huland H, Salomon G, Steuber T, Wilczak W, Sirma H, Simon R, Sauter G, Minner S, Quaas A
AM J PATHOL. 2014;184(3):609-17.

Single versus double Roux-en-Y reconstruction techniques in pancreaticoduodenectomy: a comparative single-center study
Uzunoglu F, Reeh M, Wollstein R, Melling N, Perez D, Vashist Y, Bogoevski D, Izbicki J, Bockhorn M
WORLD J SURG. 2014;38(12):3228-3234.

Loss of 4q21.23-22.1 is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
Uzunoglu F, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist Y, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki J, Wikman-Kocher H
PLOS ONE. 2014;9(12):e113315.

The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?
Uzunoglu F, Koenig A, Izbicki J
EXPERT OPIN THER TAR. 2014;18(12):1421-6.

Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score
Uzunoglu F, Reeh M, Vettorazzi E, Ruschke T, Hannah P, Nentwich M, Vashist Y, Bogoevski D, König A, Janot M, Gavazzi F, Zerbi A, Todaro V, Malleo G, Uhl W, Montorsi M, Bassi C, Izbicki J, Bockhorn M
ANN SURG. 2014;260(5):857-64.

EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer
Vashist Y, Trump F, Gebauer F, Kutup A, Güngör C, Kalinin V, Muddasar R, Vettorazzi E, Yekebas E, Brandt B, Pantel K, Izbicki J
Target Oncol. 2014;9(1):43-52.

Integrin expression in esophageal squamous cell carcinoma
Vay C, Hosch S, Stoecklein N, Klein C, Vallböhmer D, Link B, Yekebas E, Izbicki J, Knoefel W, Scheunemann P
PLOS ONE. 2014;9(11):e109026.

Individualized early goal-directed therapy in systemic Inflammation: is full utilization of preload reserve the optimal strategy?
Wodack K, Poppe A, Tomkötter L, Bachmann K, Strobel C, Bonk S, Havel J, Heckel K, Gocht A, Saugel B, Mann O, Izbicki J, Goetz A, Trepte C, Reuter D
CRIT CARE MED. 2014;42(12):e741-51.

Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.
Alsdorf W, Clauditz T, Hoenig T, Quaas A, Sirma H, Koenig A, Izbicki J, Sauter G, Marx A, Grob T
EXP MOL PATHOL. 2013;94(1):155-159.

PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma
Ameis H, Drenckhan A, Loga K, Escherich G, Wenke K, Izbicki J, Reinshagen K, Gros S
PLOS ONE. 2013;8(12):e83701.

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting
Atanackovic D, Reinhard H, Meyer S, Spöck S, Grob T, Luetkens T, Yousef S, Cao Y, Hildebrandt Y, Templin J, Bartels K, Lajmi N, Stoiber H, Kröger N, Atz J, Seimetz D, Izbicki J, Bokemeyer C
HUM VACC IMMUNOTHER . 2013;9(12):2533-42.

Is the Whipple procedure harmful for long-term outcome in treatment of chronic pancreatitis? 15-years follow-up comparing the outcome after pylorus-preserving pancreatoduodenectomy and Frey procedure in chronic pancreatitis
Bachmann K, Tomkoetter L, Kutup A, Erbes P, Vashist Y, Mann O, Bockhorn M, Izbicki J
ANN SURG. 2013;258(5):815-20; discussion 820-1.

Effects of thoracic epidural anesthesia on survival and microcirculation in severe acute pancreatitis: a randomized experimental trial
Bachmann K, Trepte C, Tomkötter L, Hinsch A, Stork J, Bergmann W, Heidelmann L, Strate T, Goetz A, Reuter D, Izbicki J, Mann O
CRIT CARE. 2013;17(6):R281.

Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer
Bohn B, Mina S, Krohn A, Simon R, Kluth M, Harasimowicz S, Quaas A, Bockhorn M, Izbicki J, Sauter G, Marx A, Stahl P
HUM PATHOL. 2013;44(8):1524-33.

Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab
Dohrmann T, Kutup A, Mahner S, Müller V, Jänicke F, Izbicki J, Vashist Y
J CLIN ONCOL. 2013;31(12):e208-10.

Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
Drenckhan A, Kurschat N, Dohrmann T, Raabe N, Koenig A, Reichelt U, Kaifi J, Izbicki J, Gros S
J SURG RES. 2013;182(2):250-6.

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert A, Mauermann O, Izbicki J, Pantel K, Riethdorf S
CLIN CHEM. 2013;59(1):252-260.

Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice
Gebauer F, Wicklein D, Stübke K, Nehmann N, Schmidt A, Salamon J, Peldschus K, Nentwich M, Adam G, Tolstonog G, Bockhorn M, Izbicki J, Wagener C, Schumacher U
GUT. 2013;62(5):741-50.

Erkrankungen des Pankreas
Gebauer F
2013.

Einfluss des zirkumferentiellen Resektionsrandes auf das Tumorrezidiv und Überleben beim pT3-Ösophaguskarzinom
Ghadban T, Vashist Y, Izbicki J, Kutup A
2013.

Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
Grob T, Hoenig T, Clauditz T, Atanackovic D, Koenig A, Vashist Y, Klose H, Simon R, Pantel K, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
Lung cancer (Amsterdam, Netherlands). 2013;79(3):221-7.

Correction: Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
Gros S, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Harms-Effenberger K, Reichelt U, Hoffmann R, Pantel K, Kaifi J, Izbicki J
PLOS ONE. 2013;8(5):.

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.
Grupp K, Kohl S, Sirma H, Simon R, Steurer S, Becker A, Adam M, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
MODERN PATHOL. 2013;26(5):733-742.

High mitochondria content is associated with prostate cancer disease progression
Grupp K, Jedrzejewska K, Tsourlakis M, Koop C, Wilczak W, Adam M, Quaas A, Sauter G, Simon R, Izbicki J, Graefen M, Huland H, Schlomm T, Minner S, Steurer S
MOL CANCER. 2013;12(1):145.

Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
Grupp K, Höhne T, Prien K, Hube-Magg C, Tsourlakis M, Sirma H, Pham T, Heinzer H, Graefen M, Michl U, Simon R, Wilczak W, Izbicki J, Sauter G, Minner S, Schlomm T, Steurer S
Experimental and molecular pathology. 2013;95(2):227-34.

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
Grupp K, Sanader S, Sirma H, Simon R, Koop C, Prien K, Hube-Magg C, Salomon G, Graefen M, Heinzer H, Minner S, Izbicki J, Sauter G, Schlomm T, Tsourlakis M
MOL ONCOL. 2013;7(6):1001-11.

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
Grupp K, Diebel F, Sirma H, Simon R, Breitmeyer K, Steurer S, Hube-Magg C, Prien K, Pham T, Weigand P, Michl U, Heinzer H, Kluth M, Minner S, Tsourlakis M, Izbicki J, Sauter G, Schlomm T, Wilczak W
PROSTATE. 2013;73(15):1690-8.

Abdominal pain in a patient with a complex history (case report)
Guthoff A, Schulze zur Wiesch C, Berliner C, Quaas A, Lange M, Bockhorn M
ULTRASCHALL MED. 2013;34(S 01):PS3_07.

Foudroyant Course of an Extensive Clostridium septicum Gas Gangrene in a Diabetic Patient with Occult Carcinoma of the Colon.
Hartel M, Kutup A, Gehl A, Zustin J, Grossterlinden L, Rueger J, Lehmann W
Case Rep Orthop. 2013;2013:216382.

Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor).
Izbicki J, Tsui T, Bohn B, Bockhorn M
J GASTROINTEST SURG. 2013;17(3):581-585.

Effects of everolimus on oxidative stress in kidney model of ischemia/reperfusion injury
Kezic A, Thaiss F, Becker J, Tsui T, Bajcetic M
AM J NEPHROL. 2013;37(4):291-301.

Stapled hemorrhoidopexy versus Milligan-Morgan hemorrhoidectomy in circumferential third-degree hemorrhoids
Kim J, Vashist Y, Thieltges S, Zehler O, Gawad K, Yekebas E, Izbicki J, Kutup A
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2013;17(7):1292-8.

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer P, Schumacher U, Grupp K, Izbicki J, Pantel K, Dikomey E, Korbel J, Plass C, Sauter G, Schlomm T, Minner S
MODERN PATHOL. 2013;26(7):975-83.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma
König A, Reeh M, Dancau A, Rathjens M, Gros S, Uzunoglu F, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki J
ANTICANCER RES. 2013;33(11):4975-82.

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
Krohn A, Seidel A, Burkhardt L, Bachmann F, Mader M, Grupp K, Eichenauer T, Becker A, Adam M, Graefen M, Huland H, Kurtz S, Steurer S, Tsourlakis M, Minner S, Michl U, Schlomm T, Sauter G, Simon R, Sirma H
AM J PATHOL. 2013;231(1):130-41.

Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer
Nentwich M, Bohn B, Uzunoglu F, Reeh M, Quaas A, Grob T, Perez D, Kutup A, Bockhorn M, Izbicki J, Vashist Y
J THORAC CARDIOV SUR. 2013;146(4):781-7.

Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues.
Nollau P, Wolters-Eisfeld G, Seyed Mortezai N, Kurze A, Klampe B, Debus A, Bockhorn M, Niendorf A, Wagener C
J HISTOCHEM CYTOCHEM. 2013;61(3):199-205.

Protein domain histochemistry (PDH)
Nollau P, Wolters-Eisfeld G, Mortezai N, Kurze A, Klampe B, Debus A, Bockhorn M, Niendorf A, Wagener C
J HISTOCHEM CYTOCHEM. 2013;61(3):199-205.

Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis
Reeh M, Bockhorn M, Görgens D, Vieth M, Hoffmann T, Simon R, Izbicki J, Sauter G, Schumacher U, Anders M
BRIT J CANCER. 2013;109(7):1848-58.

Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1
Salamon J, Derlin T, Bannas P, Busch J, Herrmann J, Bockhorn M, Hagel C, Friedrich R, Adam G, Mautner V
EUR J NUCL MED MOL I. 2013;40(5):685-92.

A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
Sauer N, Rösch T, Pezold J, Reining F, Anders M, Groth S, Schachschal G, Mann O, Aberle J
OBES SURG. 2013;23(11):1727-33.

Complications, mineral and vitamin supplementation: Comparison between Roux Y Gastric Bypass and Sleeve Gastrectomy in 171 German Subjects
Sauer N, Wienecke J, Schulze zur Wiesch C, Wolter S, Mann O, Aberle J
Surgical Science. 2013;4:547-553.

S3-Leitlinie zum exokrinen Pankreaskarzinom
Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E
Z GASTROENTEROL. 2013;51(12):1395-440.

CXCR7 expression in esophageal cancer
Tachezy M, Zander H, Gebauer F, Loga K, Pantel K, Izbicki J, Bockhorn M
J TRANSL MED. 2013;11:238.

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
Tóth I, Le A, Hartjen P, Thomssen A, Matzat V, Lehmann C, Scheurich C, Beisel C, Busch C, Degen O, Lohse A, Eiermann T, Fätkenheuer G, Meyer-Olson D, Bockhorn M, Hauber J, Lunzen J, Schulze Zur Wiesch J
J LEUKOCYTE BIOL. 2013;94(4):551-61.

The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis
Trepte C, Bachmann K, Stork J, Friedheim T, Hinsch A, Goepfert M, Mann O, Izbicki J, Goetz A, Reuter D
INTENS CARE MED. 2013;39(4):717-26.

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.
Uzunoglu F, Bockhorn M, Fink J, Reeh M, Vettorazzi E, Gawad K, Bogoevski D, Vashist Y, Tsui T, Koenig A, Mann O, Izbicki J
J GASTROINTEST SURG. 2013;17(3):494-500.

The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu F, Heumann A, Musici S, Kutup A, König A, Roch N, Thomssen A, Dohrmann T, Tsui T, Mann O, Izbicki J, Vashist Y
LUNG CANCER. 2013;79(2):151-155.

C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
Uzunoglu F, Yavari N, Bohn B, Nentwich M, Reeh M, Pantel K, Perez D, Tsui T, Bockhorn M, Mann O, Izbicki J, Wikman H, Vashist Y
Lung cancer (Amsterdam, Netherlands). 2013;81(1):123-9.

Surgery of esophageal cancer
Uzunoglu F, Reeh M, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2013;398(2):189-93.

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma
Uzunoglu F, Kolbe J, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, König A, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN ONCOL. 2013;24(5):1282-90.

Achalasie
von Renteln D, Schoenberg M, Werner Y, Mann O, Rösch T
DEUT MED WOCHENSCHR. 2013;138(23):1240-3.

Metformin after bariatric surgery--an acid problem.
Aberle J, Reining F, Dannheim V, Flitsch J, Klinge A, Mann O
EXP CLIN ENDOCR DIAB. 2012;120(3):152-153.

Effekte einer multimodalen Intervention zur Primärprävention kardiovaskulärer Krankheiten auf Depressivität, Angst und Typ-D-Muster
Albus C, Bjarnson-Wehrens B, Gysan D, Herold G, Schneider C, zu Eulenburg C, Predel H
HERZ. 2012;37(1):59-62.

Surgery in chronic pancreatitis.
Bachmann K, Mann O, Izbicki J
G Chir. 2012;33(1-2):5-9.

Fetoscopic management of gastroschisis in a lamb model.
Bergholz R, Krebs T, Wenke K, Andreas T, Tiemann B, Paetzel J, Jacobsen B, Fahje R, Schmitz C, Mann O, Roth B, Appl B, Hecher K
SURG ENDOSC. 2012;26(5):1412-1416.

Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors
Blessmann M, Gröbe A, Quaas A, Kaifi J, Mistakidis G, Bernreuther C, Sauter G, Gros S, Rawnaq T, Friedrich R, Mautner V, Smeets R, Heiland M, Schachner M, Izbicki J
ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL. 2012;113(2):239-44.

Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
Deutsch L, Wrage M, Koops S, Glatzel M, Uzunoglu F, Kutup A, Hinsch A, Sauter G, Izbicki J, Pantel K, Wikman H
GENE CHROMOSOME CANC. 2012;51(6):618-629.

[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)].
Digestive C, Diseases M, Hoffmeister A, Mayerle J, Beglinger C, Büchler M, Bufler P, Dathe K, Fölsch U, Izbicki J, Izbicki J, Kahl S, Klar E, Keller J, Knoefel W, Layer P, Loehr M, Meier R, Riemann J, Rünzi M, Schmid R, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch M
Z GASTROENTEROL. 2012;50(11):1176-1224.

Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula
Gebauer F, Kloth K, Tachezy M, Vashist Y, Cataldegirmen G, Izbicki J, Bockhorn M, Bockhorn M
ANN SURG. 2012;256(1):130-8.

Nutzen und Sicherheit der Bronchoskopie unter nichtinvasiver Beatmung bei kritisch kranken Patienten mit akuter respiratorischer Insuffizienz
Ghadban T
2012.

Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.
Grob T, Kannengiesser I, Tsourlakis M, Atanackovic D, König A, Vashist Y, Klose H, Marx A, Koops S, Simon R, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
MODERN PATHOL. 2012;25(12):1566-1573.

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
Gros S, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Harms-Effenberger K, Reichelt U, Hoffman R, Pantel K, Kaifi J, Izbicki J
PLOS ONE. 2012;7(10):47287.

CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
Gros S, Graeff H, Drenckhan A, Kurschat N, Blessmann M, Rawnaq T, Izbicki J
IN VIVO. 2012;26(4):711-718.

Goal-directed fluid therapy using stroke volume variation does not result in pulmonary fluid overload in thoracic surgery requiring one-lung ventilation.
Haas S, Eichhorn V, Hasbach T, Trepte C, Kutup A, Goetz A, Reuter D
Crit Care Res Pract. 2012;2012:687018.

Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival.
Harms-Effenberger K, Schröder C, Zu Eulenburg C, Reeh M, Tachezy M, Riethdorf S, Vashist Y, Izbicki J, Pantel K, Bockhorn M
INT J CANCER. 2012;131(4):475-483.

Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Henningsen M, Kress K, Kersten J, Kilic E, Choschzick M, Zander H, Müller V, Mahner S, Jänicke F, Wölber L, Milde-Langosch K
BMC CANCER. 2012;12:140.

Pupil evaluation in addition to Glasgow Coma Scale components in prediction of traumatic brain injury and mortality.
Hoffmann M, Lefering R, Rueger J, Kolb J, Izbicki J, Rücker A, Rupprecht M, Lehmann W, Surgery T
Br J Surg. 2012;99 Suppl 1:122-130.

[Acetylsalicylic acid protects against solid tumors].
Izbicki J, Hofmann B, Nitschmann S
INTERNIST. 2012;53(2):232-234.

Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.
König A, Reeh M, Burdelski C, Wengert C, Gawad K, Izbicki J, Bockhorn M
LANGENBECK ARCH SURG. 2012;397(8):1251-1259.

Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.
König A, Bode C, Bugger H
Heart Fail Clin. 2012;8(4):551-561.

[Emergency interventions for perforation and bleeding in esophageal cancer patients].
König A, Hofmann B, Groth S, Izbicki J
CHIRURG. 2012;83(8):719, 722-725.

Endoscopic ultrasound staging in gastric cancer
Kutup A, Vashist Y, Groth S, Vettorazzi E, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2012;44(6):572-6.

Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment?
Kutup A, Vashist Y, Groth S, Vettorazzi E, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2012;44(6):572-576.

The role of circumferential resection margin in esophageal cancer: Does it influence local recurrence and survival?
Kutup A, Ghadban T, Vashist Y, Bogoevski D, Izbicki J
J CLIN ONCOL. 2012;30(4_suppl):23.

Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Lange T, Ullrich S, Müller I, Nentwich M, Stübke K, Feldhaus S, Knies C, Hellwinkel O, Vessella R, Abramjuk C, Anders M, Schröder-Schwarz J, Schlomm T, Huland H, Sauter G, Schumacher U
CLIN CANCER RES. 2012;18(5):1364-1373.

Losses at chromosome 4q are associated with poor survival in operable ductal pancreatic adenocarcinoma.
Lübke A, Baudis M, Matthaei H, Vashist Y, Verde P, Hosch S, Erbersdobler A, Klein C, Izbicki J, Knoefel W, Stoecklein N
PANCREATOLOGY. 2012;12(1):16-22.

PTEN deletion is rare but often homogeneous in gastric cancer.
Mina S, Bohn B, Simon R, Krohn A, Reeh M, Arnold D, Bokemeyer C, Sauter G, Izbicki J, Marx A, Stahl P
J CLIN PATHOL. 2012;65(8):693-698.

High level of Ets-related gene expression has high specificity for prostate cancer
Minner S, Luebke A, Kluth M, Bokemeyer C, Jänicke F, Izbicki J, Schlomm T, Sauter G, Wilczak W
HISTOPATHOLOGY. 2012;61(3):445-53.

High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner S, Lübke A, Kluth M, Bokemeyer C, Jänicke F, Izbicki J, Schlomm T, Sauter G, Wilczak W
HISTOPATHOLOGY. 2012;61(3):445-453.

Surgery for advanced and metastatic pancreatic cancer--current state and trends
Nentwich M, Bockhorn M, König A, Izbicki J, Cataldegirmen G
ANTICANCER RES. 2012;32(5):1999-2002.

Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest.
Rana O, Schröder J, Baukloh J, Saygili E, Mischke K, Schiefer J, Marx N, Weis J, Rassaf , Kelm M, Shin D, Meyer C, Saygili E
INT J CARDIOL. 2012;Volume 168(Issue 2):1322-1327.

L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.
Rawnaq T, Quaas A, Zander H, Gros S, Reichelt U, Blessmann M, Wilczak W, Schachner M, Sauter G, Izbicki J, Kaifi J
J SURG RES. 2012;173(2):314-319.

Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction
Reeh M, Mina S, Bockhorn M, Kutup A, Nentwich M, Marx A, Sauter G, Rösch T, Izbicki J, Bogoevski D
Br J Surg. 2012;99(10):1406-14.

An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma.
Reeh M, Nentwich M, von Loga K, Schade J, Uzunoglu F, König A, Bockhorn M, Rösch T, Izbicki J, Bogoevski D
ANN THORAC SURG. 2012;93(3):890-896.

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
Roth C, Stückrath I, Pantel K, Izbicki J, Tachezy M, Schwarzenbach H
PLOS ONE. 2012;7(6):38248.

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology.
Sacco G, Joumier V, Darmon N, Dechamps A, Derreumaux A, Lee J, Piano J, Bordone N, König A, Teboul B, David R, Guerin O, Bremond F, Robert P
CLIN INTERV AGING . 2012;7:539-549.

VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Schultze A, Ben-Batalla I, Riethdorf S, Bubenheim M, Yekebas E, Erbersdobler A, Reichelt U, Harms-Effenberger K, Schmidt T, Izbicki J, Bokemeyer C, Pantel K, Fiedler W, Loges S
CLIN EXP METASTAS. 2012;29(8):879-887.

Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.
Stahl P, Kilgué A, Tennstedt P, Minner S, Krohn A, Simon R, Krause G, Izbicki J, Graefen M, Sauter G, Schlomm T, Wilczak W
PROSTATE. 2012;72(8):898-903.

ALCAM (CD166) expression and serum levels in pancreatic cancer
Tachezy M, Zander H, Marx A, Stahl P, Gebauer F, Izbicki J, Bockhorn M
PLOS ONE. 2012;7(6):e39018.

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
Tachezy M, Harms-Effenberger K, Zander H, Minner S, Gebauer F, Vashist Y, Sauter G, Pantel K, Izbicki J, Bockhorn M
INT J CANCER. 2012;131(2):396-405.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients
Tachezy M, Zander H, Gebauer F, Marx A, Kaifi J, Izbicki J, Bockhorn M
J SURG RES. 2012;177(1):e15-20.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, Koenig A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-9; discussion 679-80.

[Emergency sternotomy during percutaneous central venous catheterisation - a case report].
Uzunoglu F, König A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-263.

Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu F, Kaufmann C, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN SURG ONCOL. 2012;19(7):2159-2168.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study.
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, König A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-680.

Notfallsternotomie bei perkutaner zentralvenöser Punktion - ein Fallbericht
Uzunoglu F, Koenig A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-3.

Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with "classical" stump closure (Nissen-Bsteh).
Vashist Y, Yekebas E, Gebauer F, Tachezy M, Bachmann K, König A, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2012;397(8):1243-1249.

Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
Vashist Y, Harms-Effenberger K, Vettorazzi E, Riethdorf S, Yekebas E, Izbicki J, Pantel K
ANN SURG. 2012;255(6):1105-1112.

Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study.
von Renteln D, Inoue H, Minami H, Werner Y, Pace A, Kersten J, Much C, Schachschal G, Mann O, Keller J, Fuchs K, Rösch T
AM J GASTROENTEROL. 2012;107(3):411-417.

Peroral endoscopic myotomy for the treatment of achalasia
von Renteln D, Inoue H, Minami H, Werner Y, Pace A, Kersten J, Much C, Schachschal G, Mann O, Keller J, Fuchs K, Rösch T
AM J GASTROENTEROL. 2012;107(3):411-7.

Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel I, Schröder C, Müller V, Zander H, Tachezy M, Henningsen M, Jänicke F, Milde-Langosch K
ONCOLOGY. 2012;82(6):305-312.

Is Toupet fundoplication the procedure of choice for treating gastroesophageal reflux disease?
Bachmann K, Wachowiak R, Rempf C, Vashist Y, Mann O, Yekebas E, Izbicki J, Gawad K
Surgical endoscopy. 2011;25(10):3235-44.

Is Toupet fundoplication the procedure of choice for treating gastroesophageal reflux disease? Results of a prospective randomized experimental trial comparing three major antireflux operations in a porcine model.
Bachmann K, Wachowiak R, Rempf C, Vashist Y, Mann O, Yekebas E, Izbicki J, Gawad K
SURG ENDOSC. 2011;25(10):3235-3244.

Impact of early or delayed elective resection in complicated diverticulitis.
Bachmann K, Krause G, Rawnaq T, Tomkötter L, Vashist Y, Shahmiri S, Izbicki J, Bockhorn M
WORLD J GASTROENTERO. 2011;17(48):5274-5279.

Chronic pancreatitis: modern surgical management.
Bachmann K, Izbicki J, Yekebas E
LANGENBECK ARCH SURG. 2011;396(2):139-149.

Transoral thyroid and parathyroid surgery: still experimental!
Benhidjeb T, Witzel K, Stark M, Mann O
SURG ENDOSC. 2011;25(7):2411-2413.

Endoscopic minimally invasive thyroidectomy: ethical and patients safety considerations on the first clinical experience of an innovative approach.
Benhidjeb T, Witzel K, Burghardt J, Bärlehner E, Stark M, Mann O
SURG ENDOSC. 2011.

[Perception of natural orifice surgery. Results of a survey of female physicians and nursing staff].
Benhidjeb T, Gericke C, Spies C, Miller K, Schneider A, Müller F
CHIRURG. 2011;82(8):707-713.

Endoscopic minimally invasive thyroidectomy (eMIT): safety first!
Benhidjeb T, Stark M
WORLD J SURG. 2011;35(8):1936-1939.

Arterial en bloc resection for pancreatic carcinoma.
Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas E, Izbicki J
Br J Surg. 2011;98(1):86-92.

Chronic pancreatitis complicated by cavernous transformation of the portal vein: contraindication to surgery?
Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist Y, Yekebas E, Izbicki J, Mann O
SURGERY. 2011;149(3):321-328.

Chronic pancreatitis complicated by cavernous transformation of the portal vein
Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist Y, Yekebas E, Izbicki J, Mann O
SURGERY. 2011;149(3):321-8.

How radical should surgery be for early esophageal cancer?
Bogoevski D, Bockhorn M, König A, Reeh M, von Loga K, Sauter G, Rösch T, Izbicki J
WORLD J SURG. 2011;35(6):1311-1320.

Multivisceral resections in pancreatic cancer: identification of risk factors.
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-2763.

Multivisceral resections in pancreatic cancer
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-63.

Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F, Tachezy M, Harms-Effenberger K, von Loga K, Zander H, Marx A, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG ONCOL. 2011;104(2):140-145.

Orthotopic models of esophageal carcinoma and their use in drug discovery.
Gros S, Stephanie J
Curr Protoc Pharmacol. 2011;Chapter 14:20.

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.
Güngör C, Zander H, Harms-Effenberger K, Vashist Y, Kalinina T, Izbicki J, Yekebas E, Bockhorn M
CANCER RES. 2011;71(14):5009-5019.

Low levels of transforming growth factor-beta (TGF-beta) and reduced suppression of Th2-mediated inflammation in hyperreactive human onchocerciasis.
Korten S, Hoerauf A, Kaifi J, Büttner D
PARASITOLOGY. 2011;138(1):35-45.

Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma.
Lange T, Nentwich M, Lueth M, Yekebas E, Schumacher U
CANCER LETT. 2011;308(1):54-61.

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A, Huland H, Bokemeyer C, Yekebas E, Dierlamm J, Balabanov S, Kilic E, Wilczak W, Simon R, Sauter G, Schlomm T
PROSTATE. 2011;71(3):281-288.

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, Bokemeyer C, Huland H, Sauter G, Schlomm T
HUM PATHOL. 2011;42(12):1946-1952.

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
Moehler M, Al-Batran S, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer W, Dietrich C, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert H, Galle P, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann J, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz R, Höfler H, Höhler T, Hölscher A, Horneber M, Hübner J, Izbicki J, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause B, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer H, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag P, Schmid R, Schmidberger H, Schmiegel W, Schmoll H, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C, AWMF [
Z GASTROENTEROL. 2011;49(4):461-531.

Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome.
Nierhaus A, Frings D, Braune S, Baumann H, Schneider C, Wittenburg B, Kluge S
MINERVA ANESTESIOL. 2011;77(8):797-801.

Compartmental resection for subfascial extremity soft tissue sarcoma and quality of life in long-term survivors.
Peiper M, Matthaei H, Bölke E, Zurakowski D, Orth K, Heinecke A, Knoefel W
WIEN KLIN WOCHENSCHR. 2011;123(15-16):488-495.

Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.
Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, Brandl S, Sauter G, Izbicki J, Kaifi J
ANN SURG ONCOL. 2011;18(2):559-565.

Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.
Rawnaq T, Schwarzenbach H, Schurr P, Freise K, Brandl S, Izbicki J, Kaifi J
J SURG RES. 2011;169(1):31-35.

High surgical morbidity following distal pancreatectomy: still an unsolved problem.
Reeh M, Nentwich M, Bogoevski D, König A, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(5):1110-1117.

Transoral robotic-assisted thyroidectomy: a preclinical feasibility study in 2 cadavers.
Richmon J, Pattani K, Benhidjeb T, Tufano R
HEAD NECK-J SCI SPEC. 2011;33(3):330-333.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-835.

ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M, Zander H, Marx A, Gebauer F, Rawnaq T, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG RES. 2011;170(2):226-232.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2011;15(5):829-35.

Post-laparoscopic mesh in post-menopausal umbilical hernia repair: a case series.
Tinelli A, Malvasi A, Manca C, Alemanno G, Bettocchi S, Benhidjeb T
MINIM INVASIV THER. 2011;20(5):290-295.

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.
Vashist Y, Loos J, Dedow J, Tachezy M, Uzunoglu F, Kutup A, Yekebas E, Izbicki J
ANN SURG ONCOL. 2011;18(4):1130-1138.

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
Vashist Y, Uzunoglu F, Deutsch L, Kalinin V, Zehler O, Alzadjali A, Kutup A, Izbicki J, Yekebas E
J SURG RES. 2011;166(2):121-127.

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.
Vashist Y, Uzunoglu F, Kutup A, Gebauer F, König A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki J, Yekebas E
J SURG ONCOL. 2011;104(3):305-311.

The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist Y, Kutup A, Musici S, Yekebas E, Mina S, Uzunoglu F, Zehler O, König A, Cataldegirmen G, Bockhorn M, Harms-Effenberger K, Kalinin V, Pantel K, Izbicki J
CELL ONCOL. 2011;34(4):281-288.

Transoral endoscopic neck surgery: feasibility and safety in a porcine model based on the example of thymectomy.
Wilhelm T, Benhidjeb T
SURG ENDOSC. 2011;25(6):1741-1746.

Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.
Windhorst S, Kalinina T, Schmid K, Blechner C, Kriebitzsch N, Hinsch R, Chang L, Herich L, Schumacher U, Mayr G
INT J CANCER. 2011;129(6):1300-1309.

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki J, Kaifi J
BMC CANCER. 2011;11:1-7.

Surgical treatment in chronic pancreatitis timing and type of procedure.
Bachmann K, Kutup A, Mann O, Yekebas E, Izbicki J
BEST PRACT RES CL GA. 2010;24(3):299-310.

[Transoral endoscopic thyroidectomy : Part 2: Surgical technique].
Benhidjeb T, Harlaar J, Kerver A, Kleinrensink G, Wilhelm T
CHIRURG. 2010;81(2):134-138.

An innovative technique for colorectal specimen retrieval: a new era of "Natural Orifice Specimen Extraction" (N.O.S.E.).
Benhidjeb T, Stark M
DIS COLON RECTUM. 2010;53(4):502-503.

Training innovations in gastroenterology and educational resources: a new vision of gastrointestinal education across Europe.
Berberat P, Wit d, Bockhorn M, Bockhorn M, Lundell L, Drenth J
EUR J GASTROEN HEPAT. 2010;22(12):1393-1396.

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Choschzick M, Lassen P, Lebeau A, Marx A, Terracciano L, Heilenkötter U, Jänicke F, Bokemeyer C, Izbicki J, Sauter G, Simon R
MODERN PATHOL. 2010;23(4):603-610.

PPFIA1 and CCND1 are frequently coamplified in breast cancer.
Dancau A, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wenke K, Monni O, Simon R
GENE CHROMOSOME CANC. 2010;49(1):1-8.

Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.
Deshaies I, Cherenfant J, Gusani N, Jiang Y, Harvey H, Kimchi E, Kaifi J, Staveley-O'Carroll K
Ther Clin Risk Manag. 2010;6:453-458.

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal A, Brüchmann M, Zustin J, Isbarn H, Hellwinkel O, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf T, Izbicki J, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T
CLIN CANCER RES. 2010;16(1):56-64.

Orthotopic fluorescent peritoneal carcinomatosis model of esophageal cancer.
Gros S, Dohrmann T, Rawnaq T, Kurschat N, Bouvet M, Wessels J, Hoffmann R, Izbicki J, Kaifi J
ANTICANCER RES. 2010;30(10):3933-3938.

Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma.
Gros S, Kurschat N, Dohrmann T, Reichelt U, Dancau A, Peldschus K, Adam G, Hoffman R, Izbicki J, Kaifi J
MOL CANCER THER. 2010;9(7):2037-2045.

Indications and approach to surgical resection of lung metastases.
Kaifi J, Gusani N, Deshaies I, Kimchi E, Reed M, Mahraj R, Staveley-O'Carroll K
J SURG ONCOL. 2010;102(2):187-195.

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T, Bockhorn M, Kaifi J, Thieltges S, Güngör C, Harms-Effenberger K, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki J, Yekebas E
INT J CANCER. 2010;127(8):1931-1940.

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Murga-Penas E, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Harms-Effenberger K, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2010;10:295.

[Timing and concepts of surgical treatment of upper gastrointestinal haemorrhage].
König A, Gawad K, Yekebas E, Seewald S, Izbicki J
ZBL CHIR. 2010;135(1):65-69.

Transforming growth factor-beta expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia.
Korten S, Kaifi J, Büttner D, Hoerauf A
MICROBES INFECT. 2010;12(7):555-564.

Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Kutup A, Yekebas E, Izbicki J
Recent Results Cancer Res. 2010;182:115-125.

19q13 amplification is associated with high grade and stage in pancreatic cancer.
Kuuselo R, Simon R, Karhu R, Tennstedt P, Marx A, Izbicki J, Yekebas E, Sauter G, Kallioniemi A
GENE CHROMOSOME CANC. 2010;49(6):569-575.

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
Marx A, Zielinski M, Kowitz C, Dancau A, Thieltges S, Simon R, Choschzick M, Yekebas E, Kaifi J, Mirlacher M, Atanackovic D, Brümmendorf T, Fiedler W, Bokemeyer C, Izbicki J, Sauter G
HISTOPATHOLOGY. 2010;57(3):418-426.

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.
Marx A, Burandt E, Choschzick M, Simon R, Yekebas E, Kaifi J, Mirlacher M, Atanackovic D, Bokemeyer C, Fiedler W, Terracciano L, Sauter G, Izbicki J
HUM PATHOL. 2010;41(11):1577-1585.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos J, Stocken D, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore M, Gallinger S, Mariette C, Wente M, Izbicki J, Friess H, Lerch M, Dervenis C, Oláh A, Butturini G, Doi R, Lind P, Smith D, Valle J, Palmer D, Buckels J, Thompson J, McKay C, Rawcliffe C, Büchler M
JAMA-J AM MED ASSOC. 2010;304(10):1073-1081.

Coexpression of MAGE-A peptides and HLA class I molecules in hepatocellular carcinoma.
Roch N, Kutup A, Vashist Y, Yekebas E, Kalinin V, Izbicki J
ANTICANCER RES. 2010;30(5):1617-1623.

Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS).
Shukla P, Barreto S, Fingerhut A, Bassi C, Büchler M, Dervenis C, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Traverso W, Yeo C, Wente M
SURGERY. 2010;147(1):144-153.

Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC.
Simon F, Bockhorn M, Praha C, Baba H, Broelsch C, Frilling A, Weber F
LANGENBECK ARCH SURG. 2010;395(4):395-405.

Natural orifice surgery (NOS)--toward a single-port transdouglas approach for intra-abdominal procedures.
Stark M, Renzo D, Benhidjeb T, Benhidjeb T
EUR J OBSTET GYN R B. 2010;148(2):114-117.

Omental infarction in the postpartum period: a case report and a review of the literature.
Tachezy M, Grotelüschen R, Gebauer F, Marx A, Izbicki J, Kaifi J
J Med Case Rep. 2010;4:368.

Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M, Reichelt U, Melenberg T, Gebauer F, Izbicki J, Kaifi J
HISTOL HISTOPATHOL. 2010;25(10):1239-1246.

Periampullary gangliocytic paraganglioma: a case report.
von Loga K, König A, Zustin J
IN VIVO. 2010;24(3):321-324.

Y-box-binding protein-1 is a potential novel tumour marker for neuroblastoma.
Wachowiak R, Thieltges S, Rawnaq T, Kaifi J, Fiegel H, Metzger R, Quaas A, Mertens P, Till H, Izbicki J
ANTICANCER RES. 2010;30(4):1239-1242.

[Transoral endoscopic thyroidectomy. Part 1: rationale and anatomical studies].
Wilhelm T, Harlaar J, Kerver A, Kleinrensink G, Benhidjeb T
CHIRURG. 2010;81(1):50-55.

Surgical anatomy of the floor of the oral cavity and the cervical spaces as a rationale for trans-oral, minimal-invasive endoscopic surgical procedures: results of anatomical studies.
Wilhelm T, Harlaar J, Kerver A, Kleinrensink G, Benhidjeb T
EUR ARCH OTO-RHINO-L. 2010;267(8):1285-1290.

Quo vadis STARR? A prospective long-term follow-up of stapled transanal rectal resection for obstructed defecation syndrome.
Zehler O, Vashist Y, Bogoevski D, Bockhorn M, Yekebas E, Izbicki J, Kutup A
J GASTROINTEST SURG. 2010;14(9):1349-1354.

Quo vadis STARR?
Zehler O, Vashist Y, Bogoevski D, Bockhorn M, Yekebas E, Izbicki J, Kutup A, Bockhorn M
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(9):1349-54.

Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time.
Aberle J, Freier A, Busch P, Mommsen N, Beil F, Dannheim V, Mann O
OBES SURG. 2009;19(11):1504-1507.

[Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas]
Amosenko F, Kazubskaia T, Gromyko O, Matveeva T, Korchagina E, Nasedkina T, Gar'kavtseva R, Kalinin V
MOL BIOL (MOSK). 2009;43(3):414-421.

Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer.
Bachmann K, Shahmiri S, Kaifi J, Schurr P, Mann O, Rawnaq T, Block S, Kalinin V, Izbicki J, Strate T
J GASTROINTEST SURG. 2009;13(2):181-187.

Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement.
Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Schurr P, Busch C, Thayssen G, Izbicki J, Strate T
SURGERY. 2009;145(4):392-398.

Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.
Bachmann K, Standl N, Kaifi J, Busch P, Winkler E, Mann O, Izbicki J, Strate T
SURG ENDOSC. 2009;23(7):1587-1593.

Natural orifice surgery on thyroid gland: totally transoral video-assisted thyroidectomy (TOVAT): report of first experimental results of a new surgical method.
Benhidjeb T, Wilhelm T, Harlaar J, Kleinrensink G, Schneider T, Stark M
SURG ENDOSC. 2009;23(5):1119-1120.

Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M, Pohlenz P, Atac A, Kaifi J, Zu Eulenburg C, Kalinin V, Merkert P, Smeets R, Heiland M, Blake F, Schmelzle R, Izbicki J
INT J ORAL MAX SURG. 2009;38(7):779-784.

Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases.
Bockhorn M, Sotiropoulos G, Neuhaus J, Sgourakis G, Sheu S, Molmenti E, Fingas C, Trarbach T, Frilling A, Broelsch C
INT J COLORECTAL DIS. 2009;24(7):845-850.

Major liver resections in the elderly-is an aggressive approach justified?
Bockhorn M, Sotiropoulos G, Sgourakis G, Neuhaus J, Molmenti E, Lang H, Frilling A, Broelsch C
INT J COLORECTAL DIS. 2009;24(1):83-86.

Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.
Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist Y, Mann O, Deutsch L, König A, Izbicki J, Yekebas E
ANN SURG ONCOL. 2009;16(5):1212-1221.

Crossing the Rubicon
Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist J, Mann O, Liebl L, König A, Izbicki J, Yekebas E
ANN SURG ONCOL. 2009;16(5):1212-21.

Alveolar recruitment strategy and high positive end-expiratory pressure levels do not affect hemodynamics in morbidly obese intravascular volume-loaded patients.
Bohm S, Thamm O, Von Sandersleben A, Bangert K, Langwieler T, Tusman G, Strate T, Standl T
ANESTH ANALG. 2009;109(1):160-163.

[Operative technique and outcome in metabolic surgery: conventional and banded gastric bypass]
Busch P, Wolter S, Rawnaq T, Kaifi J, Aberle J, Izbicki J, Mann O
ZBL CHIR. 2009;134(1):32-37.

Extended central pancreatic resection as an alternative for extended left or extended right resection for appropriate pancreatic neoplasms.
Cataldegirmen G, Schneider C, Bogoevski D, König A, Kaifi J, Bockhorn M, Deutsch L, Vashist Y, Izbicki J, Yekebas E
SURGERY. 2009.

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Gnjatic S, Cao Y, Reichelt U, Yekebas E, Nölker C, Marx A, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling K, Cerundolo V, Luetkens T, Ritter G, Friedrichs K, Leuwer R, Hegewisch-Becker S, Izbicki J, Bokemeyer C, Old L, Atanackovic D
INT J CANCER. 2009.

Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.
Gros S, Dohrmann T, Peldschus K, Schurr P, Kaifi J, Kalinina T, Reichelt U, Mann O, Strate T, Adam G, Hoffman R, Izbicki J
INT J CANCER. 2009.

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann A, Kaifi J, Vallböhmer D, Yekebas E, Grimminger P, Leers J, Izbicki J, Hölscher A, Schneider P, Metzger R, Brabender J
J SURG ONCOL. 2009;100(5):414-417.

Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.
Hou Y, Grabellus F, Weber F, Zhou Y, Tan Y, Li J, Shen K, Qin J, Sun Y, Qin X, Bockhorn M, Gerken G, Broelsch C, Frilling A
J GASTROINTEST SURG. 2009;13(9):1583-1592.

The role of vascular adhesion molecules PECAM-1 (CD 31), VCAM-1 (CD 106), E-selectin (CD62E) and P-selectin (CD62P) in severe porcine pancreatitis.
Kleinhans H, Kaifi J, Mann O, Reinknecht F, Freitag M, Hansen B, Schurr P, Izbicki J, Strate T
HISTOL HISTOPATHOL. 2009;24(5):551-557.

Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour
Koenig A, Quaas A, Ries T, Yekebas E, Gawad K, Vashist Y, Burdelski C, Mann O, Izbicki J, Erbersdobler A
J Med Case Rep. 2009;3:62.

Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour: a case report.
König A, Quaas A, Ries T, Yekebas E, Gawad K, Vashist Y, Burdelski C, Mann O, Izbicki J, Erbersdobler A
J Med Case Rep. 2009;3:62.

Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma.
König A, Prenzel K, Bogoevski D, Yekebas E, Bubenheim M, Faithova L, Vashist Y, Gawad K, Baldus S, Pantel K, Schneider P, Hölscher A, Izbicki J
ANN SURG ONCOL. 2009;16(2):454-462.

For which type of chronic pancreatitis is the "Hamburg procedure" indicated?
Kutup A, Vashist Y, Kaifi J, Yekebas E, Izbicki J
J HEPATO-BILIARY-PAN. 2009.

Superficial soft tissue sarcomas of the extremities and trunk.
Lachenmayer A, Yang Q, Eisenberger C, Boelke E, Poremba C, Heinecke A, Ohmann C, Knoefel W, Peiper M
WORLD J SURG. 2009;33(8):1641-1649.

Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O, Tiefenbacher W, Kaifi J, Schneider C, Kluth D, Blöchle C, Yekebas E, Izbicki J, Strate T
PANCREAS. 2009;38(1):58-64.

Therapeutic small-volume resuscitation preserves pancreatic microcirculation in acute experimental pancreatitis of graded severity in rats.
Mann O, Kaifi J, Blöchle C, Schneider C, Yekebas E, Kluth D, Izbicki J, Strate T
PANCREATOLOGY. 2009;9(5):652-661.

HER-2 amplification is highly homogenous in gastric cancer.
Marx A, Tharun L, Muth J, Dancau A, Simon R, Yekebas E, Kaifi J, Mirlacher M, Brümmendorf T, Bokemeyer C, Izbicki J, Sauter G
HUM PATHOL. 2009;40(6):769-777.

Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A, Wandrey T, Simon P, Wewer A, Grob T, Reichelt U, Minner S, Simon R, Spehlmann M, Tigges W, Soehendra N, Seitz U, Seewald S, Izbicki J, Yekebas E, Kaifi J, Mirlacher M, Terracciano L, Fleischmann A, Raedler A, Sauter G
HUM PATHOL. 2009;40(2):166-173.

Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T, Kleinhans H, Uto M, Schurr P, Reichelt U, Cataldegirmen G, Gawad K, Yekebas E, Schachner M, Izbicki J, Kaifi J
ANTICANCER RES. 2009;29(4):1195-1199.

[Lateral anastomosis techniques: Partington-Rochelle and V-shaped excision]
Schneider C, Cataldegirmen G, Mann O, Yekebas E, Izbicki J
CHIRURG. 2009;80(1):28-33.

Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
Schurr P, Kohrs D, Reichelt U, Kaifi J, Vashist Y, Bachmann K, Bogoevski D, Yekebas E, Izbicki J
DIGEST SURG. 2009;26(3):229-235.

Clinical Value of Loss of Heterozygosity in Serum Microsatellite DNA of Patients With Gastrointestinal Stromal Tumors.
Schurr P, Oikonomou D, Kaifi J, Merkert P, Wolter S, Kleinhans H, Reichelt U, Mann O, Gawad K, Strate T, Yekebas E, Izbicki J
J CLIN GASTROENTEROL. 2009;43(1):27-35.

Repeated surgery improves survival in recurrent gastrointestinal stromal tumors
Schurr P, Kohrs D, Reichelt U, Kaifi J, Vashist Y, Bachmann K, Bogoevski D, Yekebas E, Izbicki J
DIGEST SURG. 2009;26(3):229-35.

Major liver resections for primary liver malignancies in the elderly.
Sgourakis G, Sotiropoulos G, Bockhorn M, Fouzas I, Radtke A, Molmenti E, Drühe N, Broelsch C, Karaliotas C, Lang H
ACTA CHIR BELG. 2009;109(3):340-344.

COX-2 expression in highly aggressive thyroid malignancies - indication for a possible therapeutic option?
Sheu S, Grabellus F, Schwertheim S, Mann K, Ensinger C, Ofner D, Bockhorn M, Fuhrer D, Schmid K
HORM METAB RES. 2009;41(4):314-319.

R0 liver resections for primary malignant liver tumors in the noncirrhotic liver
Sotiropoulos G, Bockhorn M, Sgourakis G, Brokalaki E, Molmenti E, Neuhäuser M, Radtke A, Wohlschlaeger J, Baba H, Broelsch C, Lang H
DIGEST DIS SCI. 2009;54(4):887-94.

Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature.
Tachezy M, Simon P, Ilchmann C, Vashist Y, Izbicki J, Gawad K
BMC INFECT DIS. 2009;9:194.

Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour
Vashist Y, Uzunoglu G, Cataldegirmen G, Kalinin V, Schurr P, Koenig A, Thieltges S, Zehler O, Schneider C, Izbicki J, Yekebas E
HISTOPATHOLOGY. 2009;54(3):303-8.

Monitoring of the recurrent laryngeal nerve in totally endoscopic thyroid surgery.
Witzel K, Benhidjeb T
EUR SURG RES. 2009;43(2):72-76.

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M, Ruosaari S, Eijk P, Kaifi J, Hollmén J, Yekebas E, Izbicki J, Brakenhoff R, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H
CLIN CANCER RES. 2009;15(5):1566-1574.

HER-2/neu analysis in breast cancer bone metastases.
Zustin J, Boddin K, Tsourlakis M, Burandt E, Mirlacher M, Jänicke F, Izbicki J, Rüther W, Rueger J, Bokemeyer C, Simon R, Sauter G
J CLIN PATHOL. 2009;62(6):542-546.

Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes.
Aberle J, Flitsch J, Beck N, Mann O, Busch P, Peitsmeier P, Beil F
MOL GENET METAB. 2008;95(3):188-191.

Chronic pancreatitis--a surgeons' view.
Bachmann K, Mann O, Izbicki J, Strate T
MED SCI MONITOR. 2008;14(11):198-205.

[A new cholecystectomy with no visible scarring and low risk. A possible alternative to natural orifice transluminal endoscopic surgery]
Bachmann K, Izbicki J, Strate T
CHIRURG. 2008.

Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients.
Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Busch C, Thayssen G, Izbicki J, Strate T
SURG ENDOSC. 2008;22(11):2470-2477.

Yield and safety of bedside open lung biopsy in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome.
Baumann H, Kluge S, Balke L, Yekebas E, Izbicki J, Amthor M, Kreymann K, Meyer A
SURGERY. 2008;143(3):426-433.

Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
Blessmann M, Kaifi J, Schurr P, Cihan A, Kalinin V, Trump F, Atac A, Heiland M, Pohlenz P, Blake F, Schmelzle R, Izbicki J
ORAL ONCOL. 2008;44(2):143-147.

Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy.
Bockhorn M, Benkö T, Opitz B, Sheu S, Sotiropoulos G, Schlaak J, Broelsch C, Lang H
LANGENBECK ARCH SURG. 2008;393(4):527-533.

Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation
Bockhorn M, Fingas C, Rauen U, Canbay A, Sotiropoulos G, Frey U, Sheu S, Wohlschläger J, Broelsch C, Schlaak J
TRANSPLANTATION. 2008;86(11):1578-85.

Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?
Bockhorn M, Frilling A, Frühauf N, Neuhaus J, Molmenti E, Trarbach T, Malagó M, Lang H, Broelsch C
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008;12(8):1399-405.

Is it time for a new TNM classification in esophageal carcinoma?
Bogoevski D, Onken F, König A, Kaifi J, Schurr P, Sauter G, Izbicki J, Yekebas E
ANN SURG. 2008;247(4):633-641.

Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D, Chayeb H, Cataldegirmen G, Schurr P, Kaifi J, Mann O, Yekebas E, Izbicki J
J GASTROINTEST SURG. 2008;12(11):1830-1838.

Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.
Bogoevski D, Strate T, Yekebas E, Izbicki J
LANGENBECK ARCH SURG. 2008;393(6):911-917.

Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens [, Ten K, Obertop H, Izbicki J, Lanschot v
DIS ESOPHAGUS. 2008;21(6):488-495.

Late morbidity after duodenum-preserving pancreatic head resection with bile duct reinsertion into the resection cavity.
Cataldegirmen G, Bogoevski D, Mann O, Kaifi J, Izbicki J, Yekebas E
Br J Surg. 2008;95(4):447-452.

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.
Fiegel H, Kaifi J, Quaas A, Varol E, Krickhahn A, Metzger R, Sauter G, Till H, Izbicki J, Erttmann R, Kluth D
PEDIATR SURG INT. 2008;24(1):101-105.

Midkine is highly expressed in neuroblastoma tissues.
Fiegel H, Kaifi J, Wachowiak R, Quaas A, Aridome K, Ichihara-Tanaka K, Muramatsu T, Metzger R, Izbicki J, Erttmann R, Kluth D, Till H
PEDIATR SURG INT. 2008;24(12):1355-1359.

Pre-incisional epidural ropivacaine, sufentanil, clonidine, and (S)+-ketamine does not provide pre-emptive analgesia in patients undergoing major pancreatic surgery.
Gottschalk A, Freitag M, Steinacker E, Kreissl S, Rempf C, Staude H, Strate T, Standl T
BRIT J ANAESTH. 2008;100(1):36-41.

Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis
Graf K, Dietrich T, Tachezy M, Scholle F, Licha K, Stawowy P, Grafe M, Hauff P, Fleck E
MOL IMAGING. 2008;7(2):68-76.

Hyperkalaemia in a tetraplegic adolescent due to de novo sodium channel mutation.
Grgic I, Si H, Depboylu C, Höglinger G, Busch C, Heyken W, Kuhlmann U, Maier T, Köhler R, Hoyer J
NEPHROL DIAL TRANSPL. 2008;23(4):1449-1451.

A legend leaves (but not quite, we hope): Nib Soehendra.
Izbicki J, Rösch T
ENDOSCOPY. 2008;40(12):973.

Anal angina--pelvic sepsis and streptococcal toxic shock syndrome after rectoscopy and mucosal biopsy.
Kastl S, Horstkotte M, Schäfer H, Izbicki J, Scherpe S, Nierhaus A
INT J COLORECTAL DIS. 2008;23(2):225-226.

Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany.
Kozub-Witkowski E, Krause G, Frankel G, Kramer D, Appel B, Beutin L
J APPL MICROBIOL. 2008;104(2):403-410.

Bihiläre Lymphome bei nichtseminomatösem Keimzelltumor
Mann O, Kleinhans H, Gebauer F, Kaifi J, Schurr P, Izbicki J, Strate T
CHIRURG. 2008;79(9):874-6.

[Intrathoracic lesions in association with germ cell tumor of the testis]
Mann O, Kleinhans H, Gebauer F, Kaifi J, Schurr P, Izbicki J, Strate T
CHIRURG. 2008;79(9):874-876.

AMACR expression in colorectal cancer is associated with left-sided tumor localization.
Marx A, Simon P, Simon R, Mirlacher M, Izbicki J, Yekebas E, Kaifi J, Terracciano L, Sauter G
VIRCHOWS ARCH. 2008;453(3):243-248.

Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.
Scheunemann P, Stoecklein N, Rehders A, Bidde M, Metz S, Peiper M, Eisenberger C, Jan S, Knoefel W, Hosch S
LANGENBECK ARCH SURG. 2008;393(3):359-365.

Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.
Schurr P, Lentz E, Block S, Kaifi J, Kleinhans H, Cataldegirmen G, Kutup A, Schneider C, Strate T, Yekebas E, Izbicki J
J GASTROINTEST SURG. 2008;12(7):1232-1238.

Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant
Sotiropoulos G, Lang H, Saner F, Beckebaum S, Wandelt M, Molmenti E, Nadalin S, Treckmann J, Bockhorn M, Fouzas I, Malagó M, Gerken G, Broelsch C, Paul A
TRANSPL P. 2008;40(9):3196-7.

Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma
Sotiropoulos G, Kaiser G, Lang H, Molmenti E, Beckebaum S, Fouzas I, Sgourakis G, Radtke A, Bockhorn M, Nadalin S, Treckmann J, Niebel W, Baba H, Broelsch C, Paul A
TRANSPL P. 2008;40(9):3194-5.

Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels
Sotiropoulos G, Malagó M, Bockhorn M, Schmitz K, Radtke A, Molmenti E, Schaffer R, Beckebaum S, Cicinnati V, Fouzas I, Broelsch C, Lang H
HEPATO-GASTROENTEROL. 2008;55(86-87):1671-7.

Hepatocellular carcinoma as a coincidental finding in a patient undergoing surgery for focal nodular hyperplasia
Sotiropoulos G, Bockhorn M, Molmenti E, Fouzas I, Broelsch C, Lang H
LIVER INT. 2008;28(4):578-9.

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.
Stoecklein N, Hosch S, Bezler M, Stern F, Hartmann C, Vay C, Siegmund A, Scheunemann P, Schurr P, Knoefel W, Verde Pablo E, Reichelt U, Erbersdobler A, Grau R, Ullrich A, Izbicki J, Klein C
CANCER CELL. 2008;13(5):441-453.

Resection vs drainage in treatment of chronic pancreatitis: long-term results of a randomized trial.
Strate T, Bachmann K, Busch P, Mann O, Schneider C, Bruhn J, Yekebas E, Kuechler T, Blöchle C, Izbicki J
GASTROENTEROLOGY. 2008;134(5):1406-1411.

Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner
Ulmer S, Reeh M, Krause J, Herdegen T, Heldt-Feindt J, Jansen O, Rohr A
J NEUROSCI METH. 2008;172(2):168-72.

Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist Y, Blessmann M, Trump F, Kalinin V, Kutup A, Schneider C, Gawad K, Kaifi J, Schmelzle R, Izbicki J, Yekebas E
J ORAL PATHOL MED. 2008;37(8):480-484.

Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Wachowiak R, Rawnaq T, Metzger R, Quaas A, Fiegel H, Kähler N, Rolle U, Izbicki J, Kaifi J, Till H
PEDIATR SURG INT. 2008;24(12):1361-1364.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels
Yekebas E, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist Y, Schurr P, Liebl L, Thieltges S, Gawad K, Schneider C, Izbicki J
ANN SURG. 2008;247(2):300-9.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas E, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist Y, Schurr P, Liebl L, Thieltges S, Gawad K, Schneider C, Izbicki J
ANN SURG. 2008;247(2):300-309.

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.
Al-Batran S, Hartmann J, Heidel F, Stoehlmacher J, Wardelmann E, Dechow C, Düx M, Izbicki J, Kraus T, Fischer T, Jäger E
GASTRIC CANCER. 2007;10(3):145-152.

P53 is an independent prognostic factor for survival in thyroid cancer.
Bachmann K, Pawliska D, Kaifi J, Schurr P, Schwoerer J, Mann O, Kahl H, Izbicki J, Strate T
ANTICANCER RES. 2007;27(6):3993-3997.

Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?
Bockhorn M, Jain R, Munn L
LANCET ONCOL. 2007;8(5):444-448.

VEGF is important for early liver regeneration after partial hepatectomy.
Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, Biglarnia A, Kamler M, Niehues E, Frilling A, Broelsch C, Schlaak J
J SURG RES. 2007;138(2):291-299.

Vascular endothelial growth factor does not improve liver regeneration and survival after 90% subtotal liver resection.
Bockhorn M, Schöllmann S, Opitz B, Sotiropoulos G, Sheu S, Niehaus E, Trippler M, Frilling A, Broelsch C, Schlaak J
HEPATOL RES. 2007;37(5):353-359.

Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy.
Bockhorn M, Frilling A, Benko T, Best J, Sheu S, Trippler M, Schlaak J, Broelsch C
EUR SURG RES. 2007;39(1):58-63.

Active versus passive mechanisms in metastasis
Bockhorn M, Jain R, Munn L
LANCET ONCOL. 2007;8(5):444-8.

Laparoscopic gastric tailoring for huge subcardial gastrointestinal stromal tumor.
Bogoevski D, Mann O, Schurr P, Izbicki J, Strate T
JSLS-J SOC LAPAROEND. 2007;11(3):394-397.

Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.
Deutsch L, Elson F, Quaas A, Gawad K, Izbicki J
ANTICANCER RES. 2007;27(4):2897-2902.

Ileoanal-pouch reconstruction does not impair sphincter function or quality of life.
Gawad K, Wenske S, von Schrenck T, Izbicki J
HEPATO-GASTROENTEROL. 2007;54(77):1477-1482.

[A sizeable chance--surgical management of profound obesity concurrent with post-traumatic osteoarthrosis]
Gille J, Aberle J, Busch P, Mann O, Faschingbauer M, Jürgens C
UNFALLCHIRURG. 2007;110(5):450-455.

[The radioactive contamination dynamics of water body ecosystems of different types in the Chernobyl atomic station alienation zone in Belarus]
Golubev A, Sikorski- V, Kalinin V, Afonin V, Chekan G
Radiats Biol Radioecol. 2007;47(3):322-332.

TNF-alpha alters visfatin and adiponectin levels in human fat.
Hector J, Schwarzloh B, Goehring J, Strate T, Hess U, Deuretzbacher G, Hansen-Algenstaedt N, Beil F, Algenstaedt P
HORM METAB RES. 2007;39(4):250-255.

New insights in surgical pancreatology.
Izbicki J
HPB. 2007;9(2):90-91.

Management of acute cholecystitis and the surgeon's dilemma: the gun shoots both directions.
Izbicki J, Strate T
ENDOSCOPY. 2007;39(4):359-360.

Midkine as a prognostic marker for gastrointestinal stromal tumors.
Kaifi J, Fiegel H, Rafnsdottir S, Aridome K, Schurr P, Reichelt U, Wachowiak R, Kleinhans H, Yekebas E, Mann O, Ichihara-Tanaka K, Muramatsu T, Kluth D, Strate T, Izbicki J
J CANCER RES CLIN. 2007;133(7):431-435.

Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
Kaifi J, Cataldegirmen G, Wachowiak R, Schurr P, Kleinhans H, Kosti G, Yekebas E, Mann O, Kutup A, Kalinin V, Strate T, Izbicki J
ANTICANCER RES. 2007;27(1):69-73.

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer.
Kaifi J, Reichelt U, Quaas A, Schurr P, Wachowiak R, Yekebas E, Strate T, Schneider C, Pantel K, Schachner M, Sauter G, Izbicki J
MODERN PATHOL. 2007;20(11):1183-1190.

Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
Kaifi J, Rawnaq T, Schurr P, Yekebas E, Mann O, Merkert P, Link B, Kalinin V, Pantel K, Sauter G, Strate T, Izbicki J
AM J SURG. 2007;194(3):380-384.

[Levetiracetam (keppra) in epileptology]
Kalinin V
ZH NEVROL PSIKHIATR. 2007;107(3):74-77.

The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer.
Karanicolas P, Davies E, Kunz R, Briel M, Koka H, Payne D, Smith S, Hsu H, Lin P, Blöchle C, Paquet K, Guyatt G
ANN SURG ONCOL. 2007;14(6):1825-1834.

Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.
Kempf K, Hector J, Strate T, Schwarzloh B, Rose B, Herder C, Martin S, Algenstaedt P
HORM METAB RES. 2007;39(8):596-600.

Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer.
Kutup A, Link B, Schurr P, Strate T, Kaifi J, Bubenheim M, Seewald S, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2007;39(8):715-719.

Percutaneous transhepatic cholangiodrainage as rescue therapy for symptomatic biliary leakage without biliary tract dilation after major surgery.
Link B, Yekebas E, Bogoevski D, Kutup A, Adam G, Izbicki J, Krupski G
J GASTROINTEST SURG. 2007;11(2):166-170.

Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.
Link B, Reichelt U, Schreiber M, Kaifi J, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad K, Issa R, Koops S, Izbicki J, Yekebas E
ANN SURG ONCOL. 2007;14(9):2591-2599.

Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W
CLIN CANCER RES. 2007;13(1):76-80.

Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
Mautner V, Brenner W, Fünsterer C, Hagel C, Gawad K, Friedrich R
ANTICANCER RES. 2007;27(4):1819-1822.

Perceptions and beliefs about cough and tuberculosis and implications for TB control in rural Rwanda.
Ngang P, Ntaganira J, Kalk A, Wolter S, Ecks S
INT J TUBERC LUNG D. 2007;11(10):1108-1113.

Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors.
Oikonomou D, Hassan K, Kaifi J, Fiegel H, Schurr P, Reichelt U, Aridome K, Yekebas E, Mann O, Kluth D, Strate T, Izbicki J
J CANCER RES CLIN. 2007;133(12):951-955.

Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel K, König A, Schneider P, Schnickmann C, Baldus S, Schröder W, Bollschweiler E, Dienes H, Mueller R, Izbicki J, Hölscher A
ANN SURG ONCOL. 2007;14(2):954-959.

Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
Rades D, Schulte R, Yekebas E, Homann N, Schild S, Dunst J
STRAHLENTHER ONKOL. 2007;183(1):10-16.

Computer-assisted operative planning in adult living donor liver transplantation: a new way to resolve the dilemma of the middle hepatic vein.
Radtke A, Nadalin S, Sotiropoulos G, Molmenti E, Schroeder T, Valentin-Gamazo C, Lang H, Bockhorn M, Peitgen H, Broelsch C, Malagó M
WORLD J SURG. 2007;31(1):175-185.

[Neuronal and neurochemical mechanisms underlying the effect of a novel antiepileptic drug levetiracetam]
Raevski- K, Malikova L, Kalinin V
Eksp Klin Farmakol. 2007;70(2):70-74.

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.
Reichelt U, Duesedau P, Tsourlakis M, Quaas A, Link B, Schurr P, Kaifi J, Gros S, Yekebas E, Marx A, Simon R, Izbicki J, Sauter G
MODERN PATHOL. 2007;20(1):120-129.

Regulation of the inositol 1,4,5-trisphosphate receptor type I by O-GlcNAc glycosylation.
Rengifo J, Gibson C, Winkler E, Collin T, Ehrlich B
J NEUROSCI. 2007;27(50):13813-13821.

Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections.
Rohde H, Burandt E, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies A, Harris L, Horstkotte M, Knobloch J, Ragunath C, Kaplan J, Mack D
BIOMATERIALS. 2007;28(9):1711-1720.

Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.
Sabunciyan S, Kirches E, Krause G, Bogerts B, Mawrin C, Llenos I, Weis S
J NEURAL TRANSM. 2007;114(5):665-674.

Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater.
Scheunemann P, Stoecklein N, Rehders A, Bidde M, Metz S, Peiper M, Eisenberger C, Schulte Am Esch J, Knoefel W, Hosch S
HPB. 2007;9(2):135-139.

Pseudoaneurysm of the common carotid artery due to ongoing trauma from the hyoid bone.
Schneider C, Kortmann H
J VASC SURG. 2007;45(1):186-187.

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
Schurr P, Strate T, Rese K, Kaifi J, Reichelt U, Petri S, Kleinhans H, Yekebas E, Izbicki J
ANN SURG. 2007;245(2):273-281.

Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?
Schurr P, Behnke S, Kaifi J, Bogoevski D, Link B, Mann O, Strate T, Pantel K, Izbicki J, Yekebas E
DIGEST SURG. 2007;24(1):19-27.

[Monosulfated triterpene glycosides from Cucumaria okhotensis Levin et Stepanov, a new species of sea cucumbers from Sea of Okhotsk]
Sil'chenko A, Avilov S, Kalinin V, Stonik V, Kalinovski- A, Dmitrenok P, Stepanov V
Bioorg Khim. 2007;33(1):81-90.

[Arterio-venous aneurysm of splenic vessels--a rare differential diagnosis for cardio-circulatory symptoms]
Strate T, Mann O, König A, Bachmann K, Izbicki J
ZBL CHIR. 2007;132(1):77-80.

ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions.
Thore D, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Gräfe M, Fleck E, Schirner M, Graf K
BASIC RES CARDIOL. 2007;102(4):298-307.

Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic masses.
Wachowiak R, Kaifi J, Schwarzenbach H, Yekebas E, Merkert P, Schurr P, Hansen B, Reichelt U, Strate T, Pantel K, Izbicki J
DIAGN MOL PATHOL. 2007;16(3):174-178.

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
Wachowiak R, Fiegel H, Kaifi J, Quaas A, Krickhahn A, Schurr P, Erttmann R, Schachner M, Kluth D, Sauter G, Izbicki J
ANN SURG ONCOL. 2007;14(12):3575-3580.

Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.
Wachowiak R, Kaifi J, Schurr P, Merkert P, Yekebas E, Schwarzenbach H, Strate T, Sauter G, Izbicki J
ANTICANCER RES. 2007;27(1):477-481.

Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition.
Wente M, Veit J, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Yeo C, Büchler M
SURGERY. 2007;142(1):20-25.

Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).
Wente M, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Traverso L, Yeo C, Büchler M
SURGERY. 2007;142(5):761-768.

Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.
Yekebas E, Wolfram L, Cataldegirmen G, Habermann C, Bogoevski D, König A, Kaifi J, Schurr P, Bubenheim M, Nolte-Ernsting C, Adam G, Izbicki J
ANN SURG. 2007;246(2):269-280.

The role of surgery in Caroli's disease
Bockhorn M, Malagó M, Lang H, Nadalin S, Paul A, Saner F, Frilling A, Broelsch C
J AM COLL SURGEONS. 2006;202(6):928-32.

Improvement of impaired microcirculation and tissue oxygenation by hemodilution with hydroxyethyl starch plus cell-free hemoglobin in acute porcine pancreatitis.
Freitag M, Standl T, Kleinhans H, Gottschalk A, Mann O, Rempf C, Bachmann K, Gocht A, Petri S, Izbicki J, Strate T
PANCREATOLOGY. 2006;6(3):232-239.

L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.
Kaifi J, Zinnkann U, Yekebas E, Schurr P, Reichelt U, Wachowiak R, Fiegel H, Petri S, Schachner M, Izbicki J
WORLD J GASTROENTERO. 2006;12(1):94-98.

Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas.
Kaifi J, Heidtmann S, Schurr P, Reichelt U, Mann O, Yekebas E, Wachowiak R, Strate T, Schachner M, Izbicki J
ANTICANCER RES. 2006;26(2):1167-1170.

Allelic loss of Hox11L1 gene locus predicts outcome of gastrointestinal stromal tumors.
Kaifi J, Wagner M, Schurr P, Wachowiak R, Reichelt U, Yekebas E, Mann O, Vashist Y, Kleinhans H, Link B, Strate T, Kalinin V, Izbicki J
ONCOL REP. 2006;16(4):915-919.

L1 (CD171) is highly expressed in gastrointestinal stromal tumors.
Kaifi J, Strelow A, Schurr P, Reichelt U, Yekebas E, Wachowiak R, Quaas A, Strate T, Schaefer H, Sauter G, Schachner M, Izbicki J
MODERN PATHOL. 2006;19(3):399-406.

Association of rare SPINK1 gene mutation with another base substitution in chronic pancreatitis patients.
Kalinin V, Kaifi J, Schwarzenbach H, Sergeyev A, Link B, Bogoevski D, Vashist Y, Izbicki J, Yekebas E
WORLD J GASTROENTERO. 2006;12(33):5352-5356.

Oxygen radical formation does not have an impact in the treatment of severe acute experimental pancreatitis using free cellular hemoglobin.
Kleinhans H, Mann O, Schurr P, Kaifi J, Hansen B, Izbicki J, Strate T
WORLD J GASTROENTERO. 2006;12(18):2914-2918.

Living donor liver transplantation
Nadalin S, Bockhorn M, Malagó M, Valentin-Gamazo C, Frilling A, Broelsch C
HPB : the official journal of the International Hepato Pancreato Biliary Association. 2006;8(1):10-21.

Computer-gestützte Operationsplanung bei Leberlebendspenden
Radtke A, Bockhorn M, Schroeder T, Lang H, Paul A, Nadalin S, Saner F, Schenk A, Broelsch C, Malagó M
ZBL CHIR. 2006;131(1):69-74.

Effects of positive end-expiratory pressure on systemic haemodynamics, with special interest to central venous and common iliac venous pressure in liver transplanted patients
Saner F, Pavlakovic G, Gu Y, Gensicke J, Paul A, Radtke A, Bockhorn M, Fruhauf N, Nadalin S, Malagó M, Broelsch C
EUR J ANAESTH. 2006;23(9):766-71.

Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.
Schurr P, Wolter S, Kaifi J, Reichelt U, Kleinhans H, Wachowiak R, Yekebas E, Strate T, Kalinin V, Simon R, Sauter G, Schaefer H, Izbicki J
CLIN CANCER RES. 2006;12(17):5151-5157.

Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr P, Yekebas E, Kaifi J, Lasch S, Strate T, Kutup A, Cataldegirmen G, Bubenheim M, Pantel K, Izbicki J
J SURG ONCOL. 2006;94(4):307-315.

Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria
Sotiropoulos G, Molmenti E, Omar O, Bockhorn M, Brokalaki E, Lang H, Frilling A, Broelsch C, Malagó M
EUR J MED RES. 2006;11(11):467-70.

Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin
Vashist Y, Tiffon C, Stoupis C, Redaelli C
WORLD J GASTROENTERO. 2006;12(42):6771-8.

Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases.
Yekebas E, Schurr P, Kaifi J, Link B, Kutup A, Mann O, Wolfram L, Izbicki J
J SURG ONCOL. 2006;93(7):541-549.

Long-term follow-up in small duct chronic pancreatitis: A plea for extended drainage by "V-shaped excision" of the anterior aspect of the pancreas.
Yekebas E, Bogoevski D, Honarpisheh H, Cataldegirmen G, Habermann C, Seewald S, Link B, Kaifi J, Wolfram L, Mann O, Bubenheim M, Izbicki J
ANN SURG. 2006;244(6):940-948.

Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy.
Yekebas E, Bogoevski D, Bubenheim M, Link B, Kaifi J, Wachowiak R, Mann O, Kutup A, Cataldegirmen G, Wolfram L, Erbersdobler A, Klein C, Pantel K, Izbicki J
WORLD J GASTROENTERO. 2006;12(40):6515-6521.

Neue Techniken in der Lebertransplantation
Bockhorn M, Frilling A, Nadalin S, Weber F, Beckebaum S, Malago M, Broelsch C
Praxis (Bern 1994). 2005;94(18):735-41.

Paraganglioma-like medullary thyroid carcinoma
Bockhorn M, Sheu S, Frilling A, Molmenti E, Schmid K, Broelsch C
THYROID. 2005;15(12):1363-7.

Lebermetastasen möglichst resezieren
Broelsch C, Frilling A, Bockhorn M, Frühauf N, Beckebaum S, Paul A, Malago M
MMW Fortschr Med. 2005;147(1-2):21-4.

Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi J, Yekebas E, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki J
J NATL CANCER I. 2005;97(24):1840-1847.

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma
Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid K, Broelsch C
THYROID. 2004;14(6):468-70.

Differential gene expression in metastasizing cells shed from kidney tumors
Bockhorn M, Roberge S, Sousa C, Jain R, Munn L
CANCER RES. 2004;64(7):2469-73.

Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.
Bogoevski D, Yekebas E, Schurr P, Kaifi J, Kutup A, Erbersdobler A, Pantel K, Izbicki J
ANN SURG. 2004;240(6):991-993.

Hyperdynamic circulation in liver cirrhosis
Vashist Y, Semela D, Dufour J
MED HYPOTHESES. 2004;62(1):82-5.

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts
Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch C, Fukumura D
CLIN CANCER RES. 2003;9(11):4221-6.

Biological and molecular characterization of a new human ampullary cancer cell line
Peiper M, Alldinger I, Heller R, Pilarsky C, Schumacher U, Knoefel W, Heinecke A, Izbicki J
ANTICANCER RES. 2003;23(1A):291-8.

Distinct roles for PECAM-1, ICAM-1, and VCAM-1 in recruitment of neutrophils and eosinophils to the cornea in ocular onchocerciasis (river blindness).
Kaifi J, Diaconu E, Pearlman E
J IMMUNOL. 2001;166(11):6795-6801.

Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
Kuhn W, Rutke S, Späthe K, Schmalfeldt B, Florack G, von Hundelshausen B, Pachyn D, Ulm K, Graeff H
Cancer. 2001;92(10):2585-91.

Telomerase activity in neuroendocrine tumors
Bockhorn M, Frilling A, Clauer U, Hertl M, Broelsch C
International journal of surgical investigation. 2000;2(3):219-25.

Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma
Bockhorn M, Frilling A, Kalinin V, Schröder S, Broelsch C
EXP CLIN ENDOCR DIAB. 2000;108(1):49-53.

Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
Frilling A, Görges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch C
SURGERY. 2000;128(6):1067-74.

CD4(+) depletion selectively inhibits eosinophil recruitment to the cornea and abrogates Onchocerca volvulus keratitis (River blindness).
Hall L, Kaifi J, Diaconu E, Pearlman E
INFECT IMMUN. 2000;68(9):5459-5461.

Impaired eosinophil recruitment to the cornea in P-selectin-deficient mice in Onchocerca volvulus keratitis (River blindness).
Kaifi J, Hall L, Diaz C, Sypek J, Diaconu E, Lass J, Pearlman E
INVEST OPHTH VIS SCI. 2000;41(12):3856-3861.

Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential
Mueller J, Brebeck B, Schmalfeldt B, Kuhn W, Graeff H, Höfler H
VIRCHOWS ARCH. 2000;437(6):618-24.

No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma
Bockhorn M, Frilling A, Kalinin V, Schröder S, Broelsch C
LANGENBECK ARCH SURG. 1999;384(1):60-4.

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
Kuhn W, Schmalfeldt B, Reuning U, Pache L, Berger U, Ulm K, Harbeck N, Späthe K, Dettmar P, Höfler H, Jänicke F, Schmitt M, Graeff H
BRIT J CANCER. 1999;79(11-12):1746-51.

Disease-adapted relapse therapy for ovarian cancer: results of a prospective study
Kuhn W, Schmalfeldt B, Pache L, Späthe K, Ulm K, Renziehausen K, Nöschel H, Canzler E, Richter B, Kroner M, Tilch G, Janicke F, Graeff H
International journal of oncology. 1998;13(1):57-63.

Somatische RET-Protoonkogenmutationen bei sporadischem C-Zell-Carcinom der Schilddrüse
Frilling A, Bockhorn M, Kalinin V, Liedke M, Kaun M, Broelsch C
CHIRURG. 1997;68(8):789-93.

Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer
Türkmen B, Schmitt M, Schmalfeldt B, Trommler P, Hell W, Creutzburg S, Graeff H, Magdolen V
ELECTROPHORESIS. 1997;18(5):686-9.

Die intravenöse oder orale Etoposid-Therapie des Platin-refraktären Ovarialkarzinom-Frührezidivs. Ergebnisse einer prospektiven randomisierlen Studie
Kuhn W, Schmalfeldt B, Dose J, Pache L, Ulm K, Freitag K, Jänicke F, Graeff H
GEBURTSH FRAUENHEILK. 1996;56(2):105-10.

Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2
Schmalfeldt B, Kuhn W, Reuning U, Pache L, Dettmar P, Schmitt M, Jänicke F, Höfler H, Graeff H
CANCER RES. 1995;55(18):3958-63.

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F, Graeff H
GYNECOL ONCOL. 1994;55(3 Pt 1):401-9.

Letzte Aktualisierung aus dem FIS: 22.02.2017 - 00:21 Uhr